1. Introduction {#sec1-ijms-18-02172}
===============

The *Zanthoxylum* genus (Rutaceae) consists of 250 species worldwide, including 45 species and 13 varieties in China. *Z. bungeanum* is a species of the genus *Zanthoxylum*, widely distributed in Asian countries including China, Japan, India, Korea, etc. The fruits of *Z. bungeanum* are the most popular commercial product in the genus *Zanthoxylum*, and are largely used as a popular condiment in cooking and medicine with a long history for both medicinal and economic uses in China. So far, multiple cultivars of *HuaJiao* have been cultivated during the process, such as *Yuexigong Jiao*, *Da Hongpao*, and *Hanyuan HuaJiao* \[[@B1-ijms-18-02172],[@B2-ijms-18-02172]\]. The pericarps color of *Z. bungeanum* cultivars is bright red, and therefore these cultivars are commonly known as "*HonghuaJiao*" in Chinese \[[@B3-ijms-18-02172],[@B4-ijms-18-02172]\].

Since 1977, the *Z. bungeanum* has been listed in the Pharmacopoeia of the People's Republic of China (Ch. P), and over 30 prescriptions containing *Z. bungeanum* have been applied for the treatment of abdominal pain, toothache, dyspepsia, vomiting, diarrhea, ascariasis, eczema, etc. \[[@B5-ijms-18-02172],[@B6-ijms-18-02172],[@B7-ijms-18-02172]\]. With increasing research on *Z. bungeanum*, more than 140 chemical compounds have been isolated and identified from this plant, which includes alkaloids, terpenoids, flavonoids, and free fatty acids, as well as a small amount of inorganic elements \[[@B8-ijms-18-02172],[@B9-ijms-18-02172],[@B10-ijms-18-02172],[@B11-ijms-18-02172],[@B12-ijms-18-02172]\]. In addition, recent investigations have revealed that a wide range of pharmacological activities have been found in *Z. bungeanum*, including analgesic effects, anti-inflammatory effects, antifungal and antibacterial effects, antioxidant and anti-tumor effects, effects on the digestive and circulatory system, as well as other effects. Currently, *Z. bungeanum* pericarps remain an important traditional Chinese medicine listed in the Ch.P, and their essential oils are regarded as the indicator agent for evaluating the quality of *Z. bungeanum* pericarps \[[@B6-ijms-18-02172],[@B7-ijms-18-02172]\].

In this article, the relevant literature on *Z. bungeanum* was collected from Chinese medicine books, a series of articles of PhD. and MSc. Dissertations and scientific databases, including PubMed, Sciencedirect, Web of Science, Springer, Baidu Scholar, Elsevier, Wiley, CNKI, and others. We systematically review the multi-faceted literature on *Z. bungeanum*, including the traditional usages, the botany, and the advance of phytochemistry, pharmacology, pharmacokinetics, as well as the toxicology of this plant. Furthermore, possible research directions and new perspectives on *Z. bungeanum* are also discussed.

2. Traditional Usages {#sec2-ijms-18-02172}
=====================

*Z. bungeanum* cultivation has a long history, dating back over 2000 years both for its medicinal and economic value in China. The first description of this plant can be traced back to Shijing 2000 years ago, recording that *Z. bungeanum* was always regarded as a precious token due to its fruitful and bright red fruits. As early as the period of the pre-Qin Dynasty, the pericarps of *Z. bungeanum* have commonly been used as a special spice in important activities, with this being the earliest utilization of *Z. bungeanum* in folk life \[[@B13-ijms-18-02172]\]. In addition, pericarps are the main part of *Z. bungeanum* used as a Chinese medicine, and they are commonly stir-fried or processed by vinegar and salt-water \[[@B14-ijms-18-02172]\]. The pharmacological effects of this plant were first listed in *ShenNong BenCaoJing* (the earliest Traditional Chinese Medicine (TCM) monograph during the Eastern Han Dynasty); it was used as an herbal medicine with the function of strengthening teeth, improving eyesight, and removing cold-dampness \[[@B15-ijms-18-02172]\]. Then, the subsequent monograph, *Mingyi Bielu*, described *Z. bungeanum* with good blood-promoting activity, joint-smoothing properties, meridians-regulating and teeth-strengthening properties. In *Zhenglei Bencao*, another famous monograph on traditional Chinese medicine, *Z. bungeanum* was described as a treatment for throat impediment, vomiting, and postpartum abdominal pain, and in the Compendium of Materia Medica (*Bencao Gangmu*), *Z. bungeanum* pericarps were described as a good treatment for toothache, diarrhea, ascariasis, swelling, dampness, and others \[[@B15-ijms-18-02172],[@B16-ijms-18-02172],[@B17-ijms-18-02172]\]. In addition, *Z. bungeanum* was also recorded in other classic monographs of medicine including *Yaoxinglun*, *Shiliao bencao*, *Bencao xinbian*, *Bencao tujing* and others. The pericarps are attributive to the heart and spleen meridians with the properties of being pungent in taste and warm in nature. *Z. bungeanum* has a warming action, thus relieving pain, dispelling dampness, stopping diarrhea, and preventing itching; therefore, it can be applied to treat abdominal pain, toothache, vomiting, diarrhea, ascariasis, and other diseases caused by cold and dampness \[[@B15-ijms-18-02172],[@B16-ijms-18-02172],[@B17-ijms-18-02172]\].

Nowadays, the pericarps of *Z. bungeanum* are clinically used as an important herbal medicine for the treatment of various painful diseases (including abdominal pain induced by cold and parasitic infestation, toothache, and bruises), vomiting diseases, edematous diseases, and itching diseases. Due to its extensive and defined pharmacological activities, over 30 kinds of prescriptions were listed in different versions of Ch.P, *Zhongyao chengfang zhiji*, and *Buban biaozhun*. The forms of these prescriptions include pill, tincture, oral liquid, powders, etc., among which pills are the most commonly used form ([Table 1](#ijms-18-02172-t001){ref-type="table"}). In Western folk medicine, *Zanthoxylum* plants, as a traditional folk medicine, are commonly known as "toothache trees" due to their anesthetic or irritant properties, which renders them useful in the alleviation of acute and chronic pain \[[@B18-ijms-18-02172]\].

Additionally, *Z. bungeanum* pericarps could be widely consumed as a popular spice and one of "eight essential condiments" in cooking because of their unique pungent flavor. Apart from the common application of pericarps, its leaves also have some medicinal value and health care function; the leaves are recorded in the books of Compendium of Materia Medica as pungent in flavor, warming in nature, with the capacity to clear food retention and remove moisture. The leaves can be used to treat indigestion, itching, and painful diseases. What is more, the pericarps and leaves of *Z. bungeanum* can be widely utilized in pickles, hotpots, and traditional Chinese cuisine in order to improve taste, and fresh young leaves can be used as a topping on dishes and sauces after mixing with soy bean paste. In addition, *Z. bungeanum* seed oil is often used as an antiphlogistic and diuretic, as well as for biodiesel production, and approximately 1 million metric tons are produced annually in China \[[@B22-ijms-18-02172]\]. In addition, the root could be applied for the treatment of epigastric pains and bruises, eczema, and snake-bites \[[@B23-ijms-18-02172]\].

3. Botany {#sec3-ijms-18-02172}
=========

*Z. bungeanum* ([Figure 1](#ijms-18-02172-f001){ref-type="fig"}) is a small deciduous shrub approximately 3--7 m in height. The stems of this plant are branched, 3--8 cm in diameter, woody and grey or brown and grey with hard prickles. The leaves are 1.5--7 cm in length, 1--3 cm in width, and are light green to dark green. The flowers are unisexual, white or pale yellow, and fragrant, and clustered in inflorescences; the inflorescences are acrogenous, branched, and approximately 2--6 cm in length; the rachises are covered with pubescence; the male flowers have 5--8 stamens and a 2-lobed rudimentary gynoecium; the female flowers have 2--3 carpels. The fruits are globular, follicle, 4--5 mm in diameter, scattered with numerous warty oil dots, red or purplish-red on the outer surface and yellowish on the inner surface; the fruit tastes pungent, has a numbing sensation in the mouth and the odour is fragrant; the fruits are harvested from August to October, the seeds and foreign matter are removed, and the fruits are then dried in the sun \[[@B17-ijms-18-02172],[@B24-ijms-18-02172]\].

The distribution of *Z. bungeanum* is very wide due to its wide niche breadth. It is native to China and widely distributed in the provinces of Sichuan, Shaanxi, Yunnan, Guizhou, Gansu, etc., among which Sichuan province contains the largest production areas, famous for their high production and quality. In addition, it is also widely cultivated in the Japanese islands, the Korean peninsula, India, and other regions \[[@B25-ijms-18-02172],[@B26-ijms-18-02172]\].

4. Phytochemistry {#sec4-ijms-18-02172}
=================

To the best of our knowledge, many chemical compounds have been isolated and identified from *Z. bungeanum* between the later 1880s and the present day. Currently, more than 140 constituents have been identified from this plant; furthermore, alkaloids and terpenoids have been identified as the characteristic components. This section details phytochemical studies that have been conducted on many parts of *Z. bungeanum*, including the stem, the leaf, the seed, the pericarps, and the roots. The identified compounds are listed in the following tables and the corresponding structures are also comprehensively presented.

4.1. Alkaloids *(**1**--**35**)* {#sec4dot1-ijms-18-02172}
--------------------------------

### 4.1.1. Alkylamides {#sec4dot1dot1-ijms-18-02172}

Alkylamides, creating a strong numbing sensation in the mouth, are considered to be the main characteristic compounds. So far, more than 25 alkylamides have been isolated and identified from this plant. They are usually highly unsaturated with a unique taste because of the two or more conjugated double bonds. Hydroxy-α-sanshool (HAS), having four double bonds in the *cis*-configuration, is the active ingredient most responsible for the unique tingling sensation evoked by the pericarps of *Z. bungeanum*. HAS was first isolated from the pericarps of *Z. bungeanum* and identified by Yasuda et al. (1982) \[[@B27-ijms-18-02172]\]. There are two different viewpoints on the unique sensation produced by HAS. In vitro, HAS has been shown to activate TRPV1 and TRPA1 in sensory neurons by influx of Ca^2+^ in cells \[[@B28-ijms-18-02172]\]. Subsequently, Bautista et al. (2008) reported the activation of somatosensory neurons including small- and large- diameter cells elicited through the unique ability of HAS to inhibit two-pore potassium channels (KCNK3, KCNK9, and KCNK18) \[[@B18-ijms-18-02172]\]. However, Hydroxy-β-sanshool (HBS) with four double bonds in the all *trans*-configuration has no effect when applied to the human tongue \[[@B29-ijms-18-02172]\]. Additionally, Galopin et al. (2004) provided the minimum structure unit for the tingling sensation elicited by alkylamides ([Figure 2](#ijms-18-02172-f002){ref-type="fig"}). It is noteworthy that the all-*trans* alkylamides are tasteless, whereas the amides having a *cis* double bond are very pungent \[[@B30-ijms-18-02172],[@B31-ijms-18-02172]\] ([Table 2](#ijms-18-02172-t002){ref-type="table"}, [Figure 3](#ijms-18-02172-f003){ref-type="fig"}).

### 4.1.2. Other Alkaloids {#sec4dot1dot2-ijms-18-02172}

Apart from the alkylamides, there are also other alkaloids isolated from *Z. bungeanum*. To date, eight alkaloids isolated from *Z. bungeanum* have been reported. In 1981, zanthobungeanine, des-*N*-methylchelerythrine, 11-methoxychelerythrine, [l]{.smallcaps}-*N*-acetylanonanine, arnothianamide, and skimmianine were isolated from the roots of *Z. bungeanum* \[[@B32-ijms-18-02172]\]. Moreover, haplopine and kokusaginine were also found to be present in the pericarps of *Z. bungeanum* in 1984 \[[@B33-ijms-18-02172]\]. The chemical constituents of alkaloids and their corresponding structures are exhibited in [Table 2](#ijms-18-02172-t002){ref-type="table"} and [Figure 3](#ijms-18-02172-f003){ref-type="fig"}.

4.2. Terpenoids *(**36**--**103**)* {#sec4dot2-ijms-18-02172}
-----------------------------------

Essential oils are the principle source of the special flavor in *HuaJiao*, and terpenoids are considered to be significant components due to their relatively high percentage among these compounds. To date, more than 65 constituents of terpenoids have been identified by gas chromatography coupled with mass spectrometry, which mainly consisted of high contents of monoterpenes and sesquiterpenoids. However, the chemical constituents and contents of terpenoids constituents are different in different studies, which can be explained by genetic characteristics, growth conditions, extraction methods, and other factors \[[@B39-ijms-18-02172],[@B40-ijms-18-02172]\]. The terpenoids isolated from *Z. bungeanum* are presented in [Table 3](#ijms-18-02172-t003){ref-type="table"} and their corresponding structures are shown in [Figure 4](#ijms-18-02172-f004){ref-type="fig"}.

4.3. Flavonoids *(**104**--**129**)* {#sec4dot3-ijms-18-02172}
------------------------------------

Flavonoids are common ingredients of numerous plants all over the world. Increasing the number of flavonoids isolated from *Z. bungeanum* has attracted much attention because of their broad range of pharmacological activities including antioxidant activity, antithrombotic activity, anti-aging activity, anti-tumor activity, etc. To date, more than 25 flavonoids, displayed in [Table 4](#ijms-18-02172-t004){ref-type="table"} and [Figure 5](#ijms-18-02172-f005){ref-type="fig"}, have been identified from this plant, such as quercetin, rutin, and quercetin 3-*O*-α-[l]{.smallcaps}-rhamnoside. Yang et al. (2013) and Zhang et al. (2014) provided significant data confirming that the leaves contain abundant flavonoids with prominent antioxidant abilities \[[@B10-ijms-18-02172],[@B23-ijms-18-02172]\]. This could also explain the frequent addition of *Z. bungeanum* leaves to the Chinese diet for the promotion of human health.

4.4. Fatty Acids *(**130**--**139**)* {#sec4dot4-ijms-18-02172}
-------------------------------------

A few studies have been conducted investigating the fatty acids in *Z. bungeanum*. In 2007, palmitoleic acid was isolated from *Z. bungeanum* \[[@B47-ijms-18-02172]\]; in addition, Xia (2011) reported that eicosoic acid, tetradecanoic acid, pentadecanoic acid, hexadecanic acid, oleic acid, and stearic acid were also present in the seeds of *Z. bungeanum* \[[@B11-ijms-18-02172]\]. Lately, linolenic acid, linoleic acid, and nonanoic acid have been isolated and identified in *Z. bungeanum* \[[@B48-ijms-18-02172],[@B49-ijms-18-02172]\]. As presented in [Table 5](#ijms-18-02172-t005){ref-type="table"} and [Figure 6](#ijms-18-02172-f006){ref-type="fig"}, the fatty acids isolated and identified from *Z. bungeanum* are mainly long carbon chains with a terminal carboxyl group.

4.5. Others *(**140**--**149**)* {#sec4dot5-ijms-18-02172}
--------------------------------

As shown in [Table 6](#ijms-18-02172-t006){ref-type="table"} and [Figure 7](#ijms-18-02172-f007){ref-type="fig"}, there are also some chemical compounds isolated from *Z. bungeanum* apart from the constituents listed above: rosefuran (**140**), mycrene epoxide (**141**), perillene (**142**), vanillic acid-4-glucoside (**143**), β-sitosterol (**144**), daucosterol (**145**), isoimperatorin (**146**), methyl-4-hydroxyphenylacrylate (**147**), 7-methoxycoumarin (**148**) and xanthoxylin (**149**).

5. Pharmacology {#sec5-ijms-18-02172}
===============

To the best of our knowledge, *Z. bungeanum* has been demonstrated to possess wide-reaching pharmacological effects, including effects on the digestive system, nervous system, and circulatory system, as well as anti-inflammatory and analgesic effects, antioxidant effects and anti-tumor effects, anti-fungal and antibacterial effects, insecticidal effects, and so on. In this section, the main pharmacology activities of *Z. bungeanum* are summarized and analyzed, as listed in [Table 7](#ijms-18-02172-t007){ref-type="table"}.

5.1. Effect on the Digestive System {#sec5dot1-ijms-18-02172}
-----------------------------------

The characteristic pharmacological effect of *Z. bungeanum* on the digestive system has been comprehensively reviewed. The gastrointestinal smooth muscle in rabbits was stimulated by lower concentrations (4 mg/mL, intragastric (i.g.)) and depressed by higher concentrations (12 mg/mL, i.g.) of the water extracts of *Z. bungeanum* (WEZB), and this stimulating effect could be completely inhibited by atropine \[[@B51-ijms-18-02172],[@B52-ijms-18-02172]\]. Furthermore, Zhang et al. (1991) reported that the WEZB (2.5, 5.0, and 10 g/kg, i.g., crude herb mass equivalent) showed significant inhibiting effects on experimental gastric ulcers in mice, including the pylorus ligation ulcer, water immersion stress ulcer, indomethacin-ethanol ulcer, and hydrochloric acid ulcer; additionally, they also found that the petroleum ether extracts of *Z. bungeanum* (PEEZB) could markedly inhibit diarrhea induced by castor oil (3.0 and 6.0 mL/kg, i.g.), while the WEZB (5 and 10 g/kg, i.g., crude herb mass equivalent) exhibited strong inhibition on diarrhea caused by senna leaf, which is different from the PEEZB \[[@B53-ijms-18-02172]\]. Yuan et al. (2009) demonstrated that the essential oils of *Z. bungeanum* (EOZB) at doses of 0.1, 0.2, 0.4, and 0.8 mg/mL could dose-dependently inhibit the contraction of isolated duodenal smooth muscle of rabbits through a mechanism possibly associated with the blocking of the Ca^2+^ channel, calcium inward current, and release of intracellular calcium \[[@B54-ijms-18-02172]\]. Meanwhile, a study also reported that the EOZB strongly inhibits the contraction of the colon smooth muscle in rabbits \[[@B55-ijms-18-02172]\]. In addition, the WEZB (0.5, 1.0, and 2 g/kg, i.g., for 14 days) was reported to show great improvement in colonic shortening and body weight loss in dextran sodium sulfate (DSS)-induced experimental colitis in mice, whereas it decreased Disease activity index (DAI), a clinical parameter reflecting the severity of weight loss \[[@B56-ijms-18-02172]\]. The mechanism may be related to the reduction of pro-inflammatory cytokines such as TNF-α, IL-β, and IL-12; additionally, suppression of NF-κB p65, IκBα phosphorylation, and the TLR4 pathway was also involved \[[@B56-ijms-18-02172]\].

In addition to this, Kono et al. (2011) suggested that HAS, an active ingredient of *Z. bungeanum* pericarps, at doses of 0.3, 3.0, and 30 μmol/L, showed notable effects on improving the release of adrenomedullin (ADM) from intestinal epithelial cells in a dose-dependent manner \[[@B57-ijms-18-02172]\]; in addition, they also showed that HAS (0.3 mg/kg) could markedly enhance the colonic blood flow in colitis rats. Additionally, HAS could also significantly evoke long-distance contraction (LDC) in vitro, and the mechanism may be associated with the blockage of the KCNK9 channel in the rat proximal colon (3, 10 and 30 μM) \[[@B58-ijms-18-02172]\].

5.2. Effect on the Nervous System {#sec5dot2-ijms-18-02172}
---------------------------------

It was reported that the EOZB and WEZB could reversibly inhibit the sciatic nerve impulse conduction of toads, and the required time of 20% EOZB and 20% WEZB for blocking the nerve impulse was approximately equal to that of procaine \[[@B59-ijms-18-02172],[@B60-ijms-18-02172]\]. In addition, the polyphenol extracts from *Z. bungeanum* (PEZB) showed significant anti-depressive effects on behavioral despair models (induced by forced swimming and tail suspension) (50, 100, and 200 mg/kg, i.g.) and the underlying mechanism might involve the central monoaminergic systems \[[@B61-ijms-18-02172]\]. Furthermore, previous studies have also demonstrated that the PEZB (50, 100, and 200 mg/kg, i.g., for 21 days) could improve climacteric depression caused by chronic unpredictable stress behavior. The mechanism for this effect might be related to the reduction of depressive symptoms, which are elicited by the regulation of the nerve-endocrine system \[[@B62-ijms-18-02172]\]. In addition, it has been reported that the PEZB can upregulate the level of NE and 5-HT in the brain tissue of rats with post-stroke depression, and the mechanism may be associated with an inhibitory effect on monoamineoxidase (MAO) activity (50, 100, and 200 mg/kg, i.g., for 21 days) \[[@B63-ijms-18-02172]\]. Additionally, the PEZB (50, 100, 200 mg/kg, i.g., for 14 days) also showed anti-depressive effects in an unpredictable stress model of depression in rats and an ovariectomized model of depression in mice \[[@B64-ijms-18-02172],[@B65-ijms-18-02172]\].

One interesting study indicated that HAS (5 mg/kg, per os (p.o.)) can significantly shorten the escape latency in mice via a Morris water maze test, and this also exhibited a tendency of HAS to reduce the effect of scopolamine-induced dementia, which is probably mediated by the facilitation of ACh release \[[@B66-ijms-18-02172]\]. Additionally, it is worth noting that gx-50, an active ingredient isolated from *Z. bungeanum*, could significantly enhance the cross-platform times (1.0 mg/kg, i.p., for 2 months), inhibit the release of cytokine induced by Aβ in microglia cells (2.5, 5, 10, and 20 μM), penetrate the blood--brain barrier, improve the cognitive abilities of mice in vivo (1.0 mg/kg, i.p., for 2 months), disassemble Aβ oligomers (5 μM), inhibit Aβ-induced neuronal apoptosis, increase bax expression, and reduce neuronal Ca^2+^ influx toxicity, which strongly suggests that gx-50 is a potential candidate drug for treating Alzheimer's Disease (AD) \[[@B37-ijms-18-02172],[@B67-ijms-18-02172]\]. In one report of 2016, eight isobutylhydroxyamides were isolated and identified from the pericarps of *Z. bungeanum*, and three of them---including qinbunamide, (10*RS*,11*SR*), and (10*RS*,11*RS*)-(2*E*,6*Z*,8*E*)-10,11-dihydroxy-*N*-(2-hydroxy-2-methylpropyl)-2,6,8-dodecatrienamide)---possess the ability to potentiate the activity of nerve growth factor (NGF) to stimulate neurite outgrowth from PC12 cells at concentration of 20 μM \[[@B26-ijms-18-02172]\].

5.3. Effect on the Circulatory System {#sec5dot3-ijms-18-02172}
-------------------------------------

In 2005, the seed oil of *Z. bungeanum* (SOZB, 5, 10, and 20 mL/kg, i.g., for 4 weeks) was reported to have a notable effect on reducing cholesterol (CHOL) hyperlipidemia, triglyceride (TG), and low-density lipoprotein (LDL), as well as increasing high-density lipoprotein (HDL-C) \[[@B68-ijms-18-02172]\]. Later, Liu et al. (2007) indicated that the SOZB (2.5 mL/kg, i.g., for 10 weeks) could decrease blood lipids and lower blood viscosity through reducing high blood viscosity (HBV), high low viscosity (HLV), CHOL, TG, and increasing HDL-C \[[@B69-ijms-18-02172]\]. Furthermore, the SOZB at doses of 2.5, 5, and 10 g/kg also showed significant effect on reducing the serum levels of TG, total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), malondialdehyde (MDA), and nitric oxide (NO) through the activation of PPARγ, which indicates that SOZB is a promising novel hypolipidemic health product \[[@B70-ijms-18-02172]\]. In addition, previous studies have also demonstrated that the EOZB (2.0, 4.0, 6.0, 8.0, and 10.0 μL/mL) displays a dose-dependent relaxation of the contracted aortic muscle elicited by PE and KCl in rats, and the mechanism may decrease calcium influx and inhibit calcium channels \[[@B71-ijms-18-02172]\].

Additionally, Yang et al. (2014) indicated that both alpha-linolenic acid (ALA) and its mixture with linoleic acid (ALA: linoleic acid = 1:1) isolated from *Z. bungeanum* seeds exhibited notable effects on the circulatory system. In vivo, after being treated with 250 mg/kg ALA, the survival rate of mice subjected to collagen-adrenaline-induced thrombosis was significantly increased by at least 3.5 times compared with the control mice. Furthermore, ALA and its mixture (70 and 175 mg/kg, p.o., for 10 days) could remarkably decrease platelet aggregation, and the mixture offered a better therapeutic effect than the pure ALA compound. In addition, the effects of ALA and its mixture (50, 100, and 250 mg/kg, respectively, p.o., for 10 days) on prolonged hemorrhage and coagulation time were also proven. The mechanism for anti-thrombosis effects may be related to the reduction in PI3K and Akt expression \[[@B72-ijms-18-02172]\].

5.4. Anti-Inflammatory and Analgesic Effects {#sec5dot4-ijms-18-02172}
--------------------------------------------

*Z. bungeanum* has a long history of usage in China as an anti-itching agent as well as for the treatment of pruritus vulvae-related diseases. In accordance with the traditional usage of *Z. bungeanum*, a few studies have demonstrated that these plants possess anti-inflammatory and analgesic effects both in vitro and in vivo. In 1994, the anti-inflammatory and analgesic abilities were evaluated through many animal models. The WEZB (2.5, 5.0, and 10 g/kg, i.g., for 3 days, crude herb mass equivalent) and the ether extracts (EEZB) (1.5, 3.0, and 6.0 mL/kg, i.g.) of *Z. bungeanum* exhibited significant anti-inflammatory and analgesic effects in animal models of inflammation (dimethylbenzene-induced ear oedema test and carrageenan-induced rat paw oedema in mice) and pain (acetic acid-induced torsion test in mice) \[[@B73-ijms-18-02172]\]. Later, in 2010, the EOZB was also reported to be effective against dimethylbenzene-induced ear oedema and acetic acid-induced pain at doses of 0.05, 0.1, and 0.2 g/kg (i.g., for 14 days). At a dose of 0.1 g/kg, the WEZB showed notable activity with an inhibition ratio of 65.76% for oedema weight and 51% inhibitory value for the writhing responses \[[@B74-ijms-18-02172]\].

Moreover, Shi et al. (2011) suggested that the alkaloids from *Z. bungeanum* (AZB) could inhibit hot-plate-induced pain (118, 236, and 472 mg/kg, i.g., for 3 days) and dextran-40-induced itch-scratch responses \[[@B75-ijms-18-02172]\]. In addition, the methanol extracts of *Z. bungeanum* pericarps (MEZB) at a dose of 200 μM showed inhibitory effects in LPS-stimulated J774.1 macrophages and in LPS/IFN-γ-stimulated mouse peritoneal exudate macrophages via the inhibition of the expression of inducible nitric oxide aynthase (iNOS) mRNA. Furthermore, 4-*O*-β-[d]{.smallcaps}-glucopyranosyldihydroferulic acid isolated from the MEZB and identified by Thin-layer chromatography (TLC) behavior and the ^1^H-NMR spectrum, was reported to be effective in suppressing iNOS mRNA expression with an IC~50~ value of 6.5 μg/mL \[[@B76-ijms-18-02172]\].

In another study of formalin-induced pain in rats, USV (ultrasonic vocalization) data was significantly lower than that of the control groups after the EEZB and the WEZB treatment, and the EEZB had better analgesic effect than WEZB. Additionally, the EEZB could relieve pain caused by warming similar to Lidocaine \[[@B77-ijms-18-02172]\]. Additionally, the effects of HAS to quickly mediate pain were evaluated using recordings of cutaneous sensory fibres, whole-cell patch clamp, and calcium imaging. The results revealed that HAS (IC~50~ = 70 ± 7 μM) could inhibit the excitability of A*δ* mechanosensory nociceptors by blocking voltage-gated sodium channels to induce "fast pain" analgesia \[[@B78-ijms-18-02172]\]. In addition, the seed oil of *Z. bungeanum* (SOZB) at doses of 0.5, 1.0, and 2.0 g/kg (i.g.) could markedly inhibit the dimethylbenzene-induced auricle edema with the inhibition rates of 68.52%, 70.43%, and 71.83% for the ear weight \[[@B48-ijms-18-02172]\].

Apart from these, some compounds isolated from the pericarps of *Z. bungeanum* were found to exhibit notable anti-inflammatory effects by the suppression of nitric oxide (NO) production. Results revealed that the compounds ZP-amide D, ZP-amide E, ZP-amide F, and ZP-amide G showed inhibitory effects on nitric oxide (NO) production in LPS-stimulated RAW 264.7 macrophages, with IC~50~ values of 48.7 ± 0.32, 27.1 ± 1.15, 49.8 ± 0.38, and 39.4 ± 0.63 μM, respectively \[[@B38-ijms-18-02172]\].

5.5. Antioxidant Effect {#sec5dot5-ijms-18-02172}
-----------------------

Lu et al. (1995) reported that the WEZB potentially has the ability to reduce the production of malondialdehyde (MDA) in hepatic tissue per gram \[[@B79-ijms-18-02172]\]; in 2010, a study demonstrated that the flavonoids of water extraction, ethanol extraction, and acetone extraction from *Z. bungeanum* leaves (FWEZBL, FEEZBL, and FAEZBL) all had high scavenging activities against DPPH radicals with IC~50~ values of 24, 17.5, and 7.6 μg/mL, respectively \[[@B80-ijms-18-02172]\]. Furthermore, the antioxidant effects on the SOZB obtained by the Box-Behnken design was measured by the scavenging activity towards the DPPH radical. The results showed that extraction pressure had a positive linear effect on the antioxidant activity, whereas extraction temperature had a negative linear effect \[[@B11-ijms-18-02172]\]. A further investigation indicated that the ethanol extracts of *Z. bungeanum* leaves (EEZBL) and their sub-fractions (the ethyl acetate fraction, the acetone fraction, the acetone fraction, and the methanol fraction of the EEZBL) exhibited significant antioxidant effects on scavenging DPPH radical activity with low IC~50~ values of 40.75 ± 0.21, 13.20 ± 0.85, 18.55 ± 0.35, and 85.85 ± 2.19 μg/mL. In addition, the ethyl acetate fraction of the EEZBL was reported to possess the highest activity in the ferric reducing/antioxidant power assay (615.88 ± 1.86 μmol equiv. Trolox/g) and ABTS•^+^ radical cation decolorization assay (2147.83 ± 23.08 μmol equiv. Trolox/g) compared with the EEZBL and its sub-fraction \[[@B23-ijms-18-02172],[@B81-ijms-18-02172]\]. Li et al. (2015) demonstrated that the polysaccharide of *Z. bungeanum* (PZB) showed prominent antioxidant effects towards Fe^3+^ (EC~50~ = 0.011 mg/mL), DPPH radical (EC~50~ = 0.021 mg/mL), chelating Fe^2+^ (EC~50~ = 0.056 mg/mL), and hydroxyl radical (EC~50~ = 0.008 mg/mL) in vitro \[[@B82-ijms-18-02172]\]. At a dose of 10 mg/mL, the three fractions (\<10, 10\~30, and \>30 kDa) of polypeptide from *Z. bungeanum* seeds kernel (PZBSK) displayed remarkable capacities for DPPH radicals with DPPH radical scavenging abilities of 53 ± 1.73, 40 ± 1.32, and 32 ± 0.70% \[[@B83-ijms-18-02172]\].

In the treatment with the EEZBL (0.015%, 0.030%, and 0.045%, for 8 days), the hexanal content, the thiobarbituric acid reactive substances (TBARS) value, and the lipoxygenase (LOX) activity were remarkably lower during processing, both in the dorsal and ventral muscles \[[@B25-ijms-18-02172]\]. In addition, salted fish with the EEZBL (0.018%) and the polyphenols (0.01% chlorogenic acid, hyperoside and quercitrin) had higher endogenous antioxidant enzyme (catalase, superoxide dismutase, and glutathione peroxidase) activities, lower peroxide value (PV), and thiobarbituric acid-reactive substance (TBARS) values than those of the control \[[@B84-ijms-18-02172]\]. These findings showed that EEZBL can be regarded as a source of natural antioxidants.

Moreover, Zhang et al. (2014) revealed that some chemical compounds including quercetin, quercitrin, quercetin-3-*O*-β-[d]{.smallcaps}-glucoside, hyperoside, rutin, and isorhamnetin 3-*O*-α-[l]{.smallcaps}-rhamnoside possess strong scavenging activity against DPPH with IC~50~ values of 0.009 ± 0.001, 0.011 ± 0.001, 0.012 ± 0.001, 0.011 ± 0.001, 0.016 ± 0.001, and 0.028 ± 0.001 mM, respectively. Under peroxide stress, the protective effects of these compounds on *Escherichia coli* were also evaluated, and the results indicated that the cell growth rate increased to 1.88--5.76-fold in these compound-treated groups. Additionally, vitexin and quercitrin were found to have high inhibitory capacity on lipid peroxidation with lower IC~50~ values of 0.014 ± 0.001 and 0.013 ± 0.005 mM, respectively \[[@B23-ijms-18-02172]\].

5.6. Anti-Tumor Effect {#sec5dot6-ijms-18-02172}
----------------------

Recently, investigations into the anti-tumor effects of *Z. bungeanum* have been conducted. In vitro, the EOZB (4 mg/mL) showed significant anti-tumor effects on H22 with an inhibition rate of 76% at 72 h; in vivo, the EOZB (10, 25, 50, and 100 mg/kg) exhibited inhibitory effects on the growth of an established tumor in mice with inhibition rates of 20.15%, 40.03%, 60.25%, and 62.58%, respectively \[[@B85-ijms-18-02172]\]. In addition, the EOZB displayed anti-tumor effects on HeLa (IC~50~ = 11.2 ± 0.2 mg/mL), A549 (IC~50~ = 6.26 ± 0.05 mg/mL), k562 (IC~50~ = 1.37 ± 0.03 mg/mL), and PC12 (0.5 mg/mL\~2.0 mg/mL) in vitro \[[@B86-ijms-18-02172],[@B87-ijms-18-02172]\]. Additionally, the EOZB (IC~50~ = 0.024%, for 48 h) has been reported to possess significant anti-proliferative effect towards HaCaT in a dose- and time-dependent manner. Furthermore, Western blot analysis suggested that the mechanism of these effects is involved with the increased expression of cleaved caspase-8/9/3, PARP, Bax, and decreased Bcl-2 levels. Additionally, the EOZB also could inhibit PC-3 cells, HEp-2 cells, Hela cells, and MFC-7 cells with IC~50~ values of 0.04%, 0.021%, 0.03%, and 0.023%, respectively \[[@B88-ijms-18-02172]\]. In another investigation, sanshools could effectively suppress HepG2 cell proliferation (0\~250 μg/mL) and induce apoptosis (0\~200 μg/mL) in a time- and dose-dependent manner, and the mechanism mainly correlated with the upregulation of mRNA and protein expressions of p53 and caspase-3. In particular, the sanshools at a concentration of 250 μg/mL showed a notable inhibitory effect on HepG2 with inhibition rates of 51.2%, 73.01%, and 85.01% at 24, 48 and 72 h, respectively \[[@B89-ijms-18-02172],[@B90-ijms-18-02172]\]. Zhao et al. (2017) revealed that the EEZB (1 μg/mL\~8 μg/mL, for 48 h) could dose-dependently induce obvious apoptosis and inhibit cell growth in HepG2 cells, and the main possible mechanism is to inhibit cell proliferation and induce cell apoptosis through downregulating Mcl-1, Survivin, Bcl-xL expression and upregulating Bax expression \[[@B91-ijms-18-02172]\].

Besides, some bio-active ingredients isolated from *Z. bungeanum* also exhibited anti-tumor effects. Hyperoside isolated from *Z. bungeanum* leaves displayed inhibitory effects against SW620 cells with the half maximal inhibitory concentration values of 72.35 ± 5.46, 36.41 ± 1.36, and 19.51 ± 4.95 μM for 24, 48, and 96 h, respectively. Further investigations revealed that the mechanism of these effects may be associated with the increased production of reactive oxygen species (ROS), reduced (mitochondrial membrane potential) ΔΨm, upregulation of X protein, cytochrome c, caspase 9, apoptotic protease activating factor 1, and caspase 3, and the inhibition of the mRNA expression levels of glutathione peroxidase (GSH Px) and catalase (CAT) \[[@B92-ijms-18-02172]\]. Apart from these, the major chemical compounds of the EOZB including [d]{.smallcaps}-limonene (IC~50~ = 0.009%, *v*/*v*, for 48 h), terpinen-4-ol (IC~50~ = 0.028%, *v*/*v*, for 48 h), and β-myrcene (IC~50~ = 0.013%, *v*/*v*, for 48 h) have been proven to significantly inhibit the proliferation of HaCaT cells \[[@B88-ijms-18-02172]\].

5.7. Anti-Bacterial and Anti-Fungal Effects {#sec5dot7-ijms-18-02172}
-------------------------------------------

In 1995, after treatment with the WEZB (5 mg/mL, for 4 days, crude herb mass equivalent), the bacteria count of *Staphylococcus aureus* and *E. coli* was significantly decreased compared with the control group, and the anti-bacterial activity of the WEZB on *S. aureus* was stronger than *E. coli* \[[@B79-ijms-18-02172]\]. Later, the study of Gong et al. (2009) reported the chemical components of the EOZB, and the inhibitory activity against plant pathogenic fungi was evaluated by the mycelial growth inhibition method and the values of IC~50~. The results indicated that the EOZB had a broad spectrum of activity against phytopathogenic fungi including *Alternaria solani*, *Botryodiplodia theobromae*, *Fusarium oxysporum* f.sp. *cucumerinum*, *Fusarium oxysporum* f.sp. *niverum*, *Bipolaris maydis*, *Leptosphaeria maculans*, *Magnaporthe grisea*, *Rhizoctonia cerealis*, *Rhizoctonia solani*, *Venturia pirina*, and *Verticillium dahliae* with low IC~50~ values of 0.44, 0.48, 0.43, 0.48, 0.24, 0.13, 0.28, 0.27, 0.24, 0.41, and 0.32 mg/mL, respectively. Furthermore, the EOZB was also found to strongly inhibit the growth of *R. solani* and *R. cerealis* mycelia with IC~50~ values of 0.95 and 1.22 mg/mL, respectively \[[@B43-ijms-18-02172]\]. In addition, the EOZB also showed significant inhibitory effects towards *Bacillus subtilis*, *Salmonella*, *Staphylococcus aureus*, *Bacillus cereus*, *E. coli*, *Proteus vulgaris*, *Pentcillum Crtinum Thom*, *Aspergillus flavus*, *Aspergillus niger*, *Ruinous orgzae*, and *Saccharomyces cerevisiae* with minimum bacteriacidal (or fungicidal) concentrations of 25.0, 6.25, 25.0 , 12.5, 12.5, 12.5, 12.5, 12.5, 12.5, 25.0, and 12.5 mL/L, respectively \[[@B93-ijms-18-02172]\]. Zhu et al. (2011) suggested that the EOZB could be used as an antibacterial agent in the food industry and for the inhibition of food-borne bacteria \[[@B44-ijms-18-02172]\]. Five common food-borne bacteria---*S. aureus*, *Bacillus subtilis*, *Bacillus cereus*, *Bacillus laterosporus laubach*, and *E. coli*---were inhibited by the EOZB with minimum inhibitory concentrations (MIC) of 5.0, 1.25, 2.5, 1.25, and 2.5 mg/mL, while the minimum bactericidal concentrations (MBC) were 20, 2.5, 10, 5.0, and 5.0 mg/mL, respectively. In vitro, the EOZB (MIC = 6.25%) and α-pinene (MIC = 12.50%) showed strong inhibition against *Fusarium sulphureum* with decreased spore germination and germ tube elongation, and declined cell membrane integrity. Furthermore, in vivo testing showed that the EOZB (6.25%) and α-pinene (12.50%) effectively reduced the lesion diameter of potato inoculated with *F. sulphureum* \[[@B40-ijms-18-02172]\].

Apart from these, the antibacterial activity of the ethanol extracts and their five fractions from *Z. bungeanum* leaves against five tested plant pathogenic fungi were assayed. IC~50~ values of the EEZBL against *Botrytis cinerea*, *Piricularia oryzae*, *Physalospora piricola*, *Glomerella cingulate*, and *Venturia pyrina* were determined to be 11.82 ± 1.15, 12.31 ± 0.45, 39.48 ± 2.25, 13.00 ± 1.34, and 33.22 ± 3.61 mg/mL, while the chloroform fraction of the EEZBL against five tested pathogenic fungi with EC~50~ values were determined to be 9.39 ± 0.07, 4.18 ± 0.08, 10.89 ± 1.62, 0.83 ± 0.24, and 5.35 ± 0.34 mg/mL, respectively \[[@B81-ijms-18-02172]\]. In addition, the ethyl acetate fraction and acetone fraction of the EEZBL also showed notable inhibitory activity against *B. cinerea*, *P. oryzae*, *P. piricola*, *G. cingulate*, and *V. pyrina* \[[@B81-ijms-18-02172]\].

5.8. Insecticidal Effects {#sec5dot8-ijms-18-02172}
-------------------------

Bowers et al. (1993) reported that three active monoterpenes isolated from *Z. bungeanum*---piperitone, 4-terpineol, and linalool---exhibited high repellent activity against ants, with 80% of the ants repelled from feeding on the sucrose solution of 8.91, 14.13, and 20 μg/cm^2^ \[[@B94-ijms-18-02172]\]. It was reported that the EOZB obtained by supercritical CO~2~ had high insecticidal activity against *Sitophilus zeamais* and *Tribolium castaneum* \[[@B95-ijms-18-02172]\]. In addition, three fractions of the EOZB (petroleum ether fraction, dichloromethane fraction, and diethyl ether fraction) showed significant insecticidal effects towards *T. castaneum* with LD~50~ values of 0.0713, 0.11699, and 0.12267 μL \[[@B95-ijms-18-02172]\]. In addition, Kou (2015) suggested that the EOZB obtained by steam distillation displayed strong anti-insect activity against *aedes albopictus* at doses of 15, 25, 35, and 45 μg/mL \[[@B96-ijms-18-02172]\]. Furthermore, *T. castaneum* could be killed by the MEZB at doses of 0.5, 1.0, and 1.5 mg/mL \[[@B96-ijms-18-02172]\]. Additionally, two EOZB samples were obtained from the pericarps of *Z. bungeanum* with the methods of hydrodistillation (HD) and supercritical fluid CO~2~ extraction (SFE), and their bioactivities against *Lasioderma serricorne* adults were evaluated. The results indicated that the SFE sample and HD sample showed significant anti-insect activity against *Lasioderma serricorne* adults with LC~50~ values of 3.99 μg/mL and 12.54 μg/mL \[[@B41-ijms-18-02172]\].

Apart from these, it was revealed that some major chemical components of the EOZB (eucalyptol, limonene, γ-terpinene, linalool, *α*-terpineol and 4-terpinenol) played a key role in anti-insect activity against *L. serricorne* with LC~50~ values of 5.18, 14.07, 12.01, 18.04 3.27, and 6.90 mg/L. Moreover, these chemical compounds also exhibited strong contact toxicity against *L. serricorne* with LD~50~ values of 15.58, 13.66, 14.19, 12.74, 11.99, and 8.62 μg/adult, respectively \[[@B41-ijms-18-02172]\].

5.9. Other Pharmacological Effects {#sec5dot9-ijms-18-02172}
----------------------------------

In addition to the pharmacological effects listed above, *Z. bungeanum* also exhibited other effects. The sanshools isolated from the pericarps of *Z. bungeanum* were regarded as a topical lifting agent for wrinkles based on their capacity to relax subcutaneous muscles \[[@B97-ijms-18-02172]\]. Furthermore, the sanshools (0.8 mg/mL) of *Z. bungeanum* elicited protective effects on rice-seedling growth, chlorophyll content, and root activity in rice seedlings exposed to metolachlor; this activity was related to the upregulated expression of four Glutathione transferases (GST) genes, especially representative GST genes (OsGSTU3) \[[@B98-ijms-18-02172]\]. Tang et al. (2014) evaluated the anti-asthma effects of the seeds of *Z. bungeanum* (SZB), and they found that the SZB at doses of 0.25, 0.5, and 1.0 g/kg could obviously prolong the latency period of induced asthma (LPIA) and reduce the frequency of citric acid-induced cough compared with that of vehicle treatment. Moreover, the SZB (0.5, 1.0, and 2.0 g/kg, i.g.) also showed anti-fatigue and anti-anoxia ability \[[@B48-ijms-18-02172]\]. Additionally, Lan et al. (2014) demonstrated that the EOZB (3%) could significantly enhance the percutaneous absorption of drugs with different lipophilicities \[[@B46-ijms-18-02172]\]. Meanwhile, limonene (3%) exhibited the highest permeation fluxes and cumulative amounts in comparison with terpinen-4-ol (3%) and 1,8-cineole (3%). The mechanism of these enhancers which promoted the skin permeation of drugs may be associated with the effect on skin stratum corneum (SC) lipids \[[@B45-ijms-18-02172]\].

Apart from these, the *n*-butanol fraction isolated from the EEZB has effects on the cholesterol metabolism. In an in vivo study, it (50 and 200 mg/kg/day, i.g., for 4 weeks) can inhibit hyperlipidemia effects with decreased serum TC and TG levels in apoE-ko mice. In an in vitro study, with the *n*-butanol fraction of the EEZB treatment (0.05, 0.1, and 0.2 mg/mL), the TC, TG, FC (free cholesterol) levels and apolipoprotein B (apoB) secretion were significantly decreased in HepG2 cells exposed to sterols and 25-hydroxycholesterol, whereas apolipoprotein A1 (apoA1) secretion was increased \[[@B99-ijms-18-02172]\]. The mechanism may be related to the increase in low density lipoprotein receptor (LDLR) protein and inhibition of the expression of hydroxy methylglutaryl coenzyme A reductase, HMGCR \[[@B99-ijms-18-02172]\].

5.10. Summary of Pharmacologic Effects {#sec5dot10-ijms-18-02172}
--------------------------------------

In conclusion, *Z. bungeanum* has an extensive range of pharmacological effects which includes effects on the digestive system, effects on the nervous system, effects on the circulatory system, anti-inflammatory and analgesic effects, anti-bacterial and anti-fungal effects, as well as antioxidant effect and anti-tumor effects, etc. These pharmacological activities mainly have focused on the extraction or preparations of *Z. bungeanum*, which indicates that this plant has a promising potential for treating disease. However, there are few systemic investigations regarding the individual compounds and their corresponding pharmacological activities, as well as action mechanism. Therefore, future research into pharmacological effects, structure-function relationships, and mechanisms of the plant's bio-active components should be explored by in vivo and in vitro experiments.

6. Pharmacokinetics {#sec6-ijms-18-02172}
===================

To date, there are few pharmacokinetics studies of the extracts and compounds of this plant. Previous pharmacokinetics studies of *Z. bungeanum* mainly focused on its alkylamides including hydroxyl-α-sanshool (HAS), hydroxyl-β-sanshool (HBS), hydroxyl-γ-sanshool (HRS) and other sanshools.

After oral administration of the WEZB at a dose of 1.3 g/mL, the peak time (Tmax) and peak plasma concentration (Cmax) values were determined to be 30.0 min and 46.720 g/kg, respectively, and the t1/2 of the WEZB was 79.26 min. Furthermore, the area under the concentration-time curve (AUC) was also determined, and the AUC~0--t~ was 102.015 g/h/kg \[[@B100-ijms-18-02172]\]. Furthermore, Fang et al. (2014) reported that the t1/2 values of alkylamides were determined to be 179.33, 118.03, 134.01, and 241.51 min of different intestinal segments of rats (including duodenum, jejunum, ileum, and colon), and the jejunum was regarded as the best absorption site of alkylamides \[[@B101-ijms-18-02172]\].

In addition, a simple, rapid, and sensitive UHPLC--MS/MS method was developed for the determination of HAS, HBS, and HRS concentration in rat plasma. After the subcutaneous administration of the EEZB at a dose of 11.0 mg/kg (equivalent to 6.21 mg/kg of HAS, 1.36 mg/kg of HBS and 0.32 mg/kg of HRS), the peak times (Tmax) of HAS, HBS, and HRS were determined to be 36, 42, and 69 min, respectively, and the peak plasma concentration (Cmax) values were 1468, 432, and 41.49 ng/mL, respectively. Moreover, the area under the concentration-time curve (AUC) was also determined, and the AUC~0--t~ of HAS, HBS, and HRS were 3816, 819, and 147 ng/mL, respectively; additionally, the AUC~0--∞~ were 3890, 839, and 160 ng/mL, respectively. Meanwhile, pharmacokinetics studies of EOZB (4.4 mg/kg) after intravenous injection were also conducted. The Cmax values of HAS, HBS, and HRS were 1215, 324, and 34.70 ng/mL, respectively, and the t1/2 were 65.4, 91.2, and 99.6 min, respectively, and the AUC~0-t~ were 1498, 385, and 65 ng/mL, respectively, and the AUC~0-∞~ were 1551, 441, and 72 ng/mL, respectively. In addition, the subcutaneous absolute bioavailability were 100.2, 76.2, and 90.3% for HAS, HBS, and HRS, respectively \[[@B102-ijms-18-02172]\].

Apart from these, the study of gx-50 (20 mg/kg, p.o.) on metabolism was also determined by LC-MS/MS. The results demonstrated that gx-50 could be absorbed into the blood and penetrate the blood--brain barrier (BBB) after oral administration, and it immediately distributed to brain tissue (5 min post-per os (PO)) and was finally excreted approximately 4 h post-PO \[[@B37-ijms-18-02172]\].

7. Toxicology {#sec7-ijms-18-02172}
=============

For thousands of years, *Z. bungeanum* was commonly considered to be a traditional Chinese medicine with low toxicity \[[@B15-ijms-18-02172]\]. To date, investigations regarding the toxicities of *Z. bungeanum* are scarce, and previous studies mainly focus on its extracts ([Table 8](#ijms-18-02172-t008){ref-type="table"}). In 1995, Tong et al. (1995) demonstrated that the median lethal concentration (LD~50~) value of the WEZB in mice was 45 g/kg (i.g., crude herbs mass equal) \[[@B16-ijms-18-02172]\]. However, a report in 2010 suggested that the LD~50~ value of the WEZB in mice was 51.14 g/kg (crude herbs mass equal, i.g.), and this can be explained by the toxicity of *Z. bungeanum* which varied with the genetic characteristics, growing conditions, and medicinal materials \[[@B100-ijms-18-02172]\]. Furthermore, Zhao et al. (2003) studied the toxicity of the WEZB on the viscera of mice, and the WEZB (0.5, 1.0, 2.0, and 4 g/kg, i.g., crude herbs mass equal) showed low toxicity on liver including ballooning degeneration, cytoplasm rarefaction, and some spotty necrosis \[[@B103-ijms-18-02172]\]. In a cell-based model, the WEZB was added to J774.1 cells, and the results showed that the WEZB had no toxicity at doses of 100, 200, and 400 μg/mL \[[@B56-ijms-18-02172]\].

The toxicity of the EOZB has also been investigated in recent years. The LD~50~ value of different approaches including intragastric administration (i.g.), intraperitoneal injection (i.p.), intramuscular injection (i.m.), and hypodermic injection (i.h.) of the EOZB was determined to be 2.27, 2.03, 4.64, and 5.32 g/kg, respectively \[[@B104-ijms-18-02172]\]. After treatment with the lethal dose of EOZB, drowsiness, diarrhea, arrhythmia, twitchy limbs, and even death were observed in mice. Moreover, it has been reported that the EOZB resulted in low toxicity in both HaCaT cells and CCC-ESF-1 cells with a dose-dependent decrease in cell viability at IC~50~ values (i.e.) of 2.435 and 3.649 mg/mL, respectively \[[@B45-ijms-18-02172]\].

In conclusion, *Z. bungeanum* showed low toxicity potential for use as a flavoring and traditional Chinese medicine. The occurrence of adverse reaction to *Z. bungeanum* mainly resulted from the over-dosage or misuse of *Z. bungeanum*. Obviously, the over-dosage of these plants will cause severe adverse reactions or even death. Furthermore, certain people should take *Z. bungeanum* with caution, such as pregnant women and those with Yin deficiency \[[@B15-ijms-18-02172]\].

8. Future Perspectives and Conclusions {#sec8-ijms-18-02172}
======================================

In summary, *Z. bungeanum* Maxim. has been used in Asian countries for many years, and many kinds of chemical constituents have been isolated and identified from this plant. There is no doubt that *Z. bungeanum* is an important and effective traditional Chinese medicine and food additive with a long history. Significant breakthrough has been made on multiple aspects of this plant in the past decade. However, it is worthy to note that there are still several challenges tha require further investigation to satisfy clinical research.

First, pharmacological studies have mainly focused on crude extracts and preparation, and there is not sufficient evidence to explain the special action mechanism for the pharmacological activity of this plant. Therefore, further investigation should be carried out to study the bioactive compounds and its action mechanism and structure-function relationship. Second, there are not enough studies regarding the pharmacokinetics and clinical research of *Z. bungeanum*, and few evaluations of the toxicity on a cellular and molecular level have been explored. Thus, future study of *Z. bungeanum* should focus more on the pharmacokinetics study of other constituents besides alkylamides, and toxicity studies should be performed on its molecular and cellular level to investigate any side effects in clinical research. Third, according to the current in vivo and in vitro investigation, HAS is the main active compound responsible for the special taste and diverse pharmacological activity. However, HAS is not stable in normal storage conditions and it may be sensitive to oxygen due to the conjugated triene system \[[@B9-ijms-18-02172]\]. Therefore, more stable derivatives of HAS and other sanshools should be synthesized by modification of the structure. Fourth, traditional usages of *Z. bungeanum* include few prescriptions, and the processed products of *Z. bungeanum* are becoming fewer and fewer. Therefore, new prescriptions and products need to be developed to meet the clinical requirement. Fifth, the study of leaves, seeds, stems, and roots in *Z. bungeanum* has been relatively slow in comparison with research of pericarps, and it is necessary to investigate the chemical compounds and pharmacological activity of every part of *Z. bungeanum* to ensure the full utilization of the possible medicinal usages of this plant. Sixth, because of its rich biodiversity and morphological similarity to the *Zanthoxylum* genus, it is difficult to identify *Z. bungeanum* and its related plants. Thus, it is important to find a potential strategy that can control the quality of this plant and establish a unified international quality evaluation system. Lastly, due to its wide distribution and cultivation in many areas of the world, it is very important to enhance the efficiency and quality of the picking process.

The current literature provides a full-scale review on the progress of traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics, and toxicology of *Z. bungeanum*, and proposes some issues worth investigating in the future, which will greatly facilitate the comprehensive understanding and effective development of *Z. bungeanum* treaments and applications.
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###### 

The traditional and clinical use of *Z. bungeanum* in China.

  Preparation Name                   Main Compositions                                                                                                                                                                                                                                                                                                                                   Traditional and Clinical Usages                                                                                                                                                                          Ref.
  ---------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------
  Hua Zheng Hui Sheng Tables         Pericarpium *Zanthoxyli*, Herba *Leonuri*, Flos *Carthami*, Radix *Angelicae Sinensis*, Lignum *Sappan*, Rhizoma *Chuanxion*, *Ginseng radix* and *rhizome*, *Lignum Dalbergiae Odoriferae*                                                                                                                                                         Removing blood stasis, curing blood accumulation, postpartum blood stasis                                                                                                                                \[[@B7-ijms-18-02172]\]
  Wu Mei Pills                       Pericarpium *Zanthoxyli*, *Ginseng radix* and *rhizome*, Radix *Angelicae Sinensis*, Rhizoma *Zingiberis*, Fructus *Mume*, Herba *Asari*, Rhizoma *Coptidis*, Cortex *Phellodendri*, Radix *Aconiti Lateralis* Preparata                                                                                                                            Clearing the liver, regulating the middle burner, clearing the upper burner, warming the lower burner, and curing ascariasis, chronic dysentery, Jue Yin headache                                        \[[@B7-ijms-18-02172]\]
  Quan Lu Pills                      Pericarpium *Zanthoxyli*, *Cornu Cervi Pantotrichum*, Herba *Cynomorii*, Radix *Bupleuri*, Radix *Rehmanniae*, Radix *Achyranthis Bidentatae*, Radix *Rehmaniae* Praeparata, *Myrrha*, *Semen Cuscutae*, Fructus *Lycii*                                                                                                                            Invigorating the kidney and essence replenishment, invigorating the spleen and supplementing Qi, and curing weak waist, cold chills, deafness, tinnitus                                                  \[[@B7-ijms-18-02172]\]
  Bo Yun Tui Yi Pills                Pericarpium *Zanthoxyli*, Flos *Buddlejae*, Fructus *Tribuli*, Flos *Chrysanthemi*, Herba *Equiseti Hiemalis*, *Feriostracum Serpentis*, Herba *Schizonepetae*, Fructus *Viticis*, Herba *Menthae*, Radix *Angelicae Sinensis*, Rhizoma *Chuanxion*                                                                                                 Cleaning heat, removing wind, and improving eyesight and curing blurred vision caused by wind-heat                                                                                                       \[[@B7-ijms-18-02172]\]
  Tong Luo Qu Tong Gao               Pericarpium *Zanthoxyli*, Radix *Angelicae Sinensis*, Rhizoma *Chuanxion*, Flos *Carthami*, Fructus *Piperis*, Flos *Caryophylli*, Cortex *Cinnamomi*, Fructus *Piperis Longi*, Rhizoma *Zingiberis*, *Camphora*, *Borneolum Syntheticum*                                                                                                           Promoting blood circulation, removing meridian obstruction, dispelling cold, removing dampness, relieving swell and pain, and curing blood stagnation as well as cold dampness blocking in collaterals   \[[@B7-ijms-18-02172]\]
  Kang Fu Ruan Gao                   Pericarpium *Zanthoxyli*, Radix *Angelicae Dahuricae*, Fructus *Cnidii*, Radix *Inulae*, *Borneolum Syntheticum*                                                                                                                                                                                                                                    Curing pruritus valvae, leucorrhea disease, itching                                                                                                                                                      \[[@B7-ijms-18-02172]\]
  Zi Hua Shao Shang Ruan Gao         Pericarpium *Zanthoxyli*, Radix *Arnebiae Seu Lithospermi*, Radix *Rehmanniae*, Prepared Radix *Rehmanniae*, *Borneolum Syntheticum*, Rhizoma *Coptidis*, Radix *Glycyrrhizae*, Rhizoma *Coptidis*, Radix *Angelicae Sinensis*                                                                                                                      Curing burning and scalding disease                                                                                                                                                                      \[[@B7-ijms-18-02172]\]
  Chang Chun Yao Jiu                 Pericarpium *Zanthoxyli*, Rhizoma *Atractylodis*, Prepared Radix *Rehmanniae*, Fructus *Gardeniae*, Fructus *Amomi Rotundus*, Herba *Epimedii*, Radix *Achyranthis Bidentatae*, *Psoralea corylifolia Linn*, Radix *Paeoniae Alba*, Cortex *Eucommiae*                                                                                              Curing backache caused by deficiency of the kidney, rheumatism, debility, and weak blood                                                                                                                 \[[@B19-ijms-18-02172]\]
  Qian Zi Hong Ke Li                 Pericarpium *Zanthoxyli*, *Geranium strictipes Knuth*, Herba *Senecionis Scandentis*, Cortex *Schizophragmatis Integrifolii Radicis*, Radix *Myricae Rubrae*                                                                                                                                                                                        Curing dysentery, diarrhea caused by summer heat, dampness, and dyspepsia                                                                                                                                \[[@B19-ijms-18-02172]\]
  Shen Rong Gu Ben Huan Shao Pills   *Pericarpium Zanthoxyli*, *Ginseng radix andrhizome*, *Radix Aconiti Lateralis Preparata Cornu Cervi Pantotrichum*, *Cortex Cinnamomi*, *Semen Cuscutae*, *Cortex Eucommiae*, *Herba Epimedii*, *Radix Achyranthis Bidentatae*, *Actinolitum*                                                                                                       Reinforcing the kidneys to strengthen Yang, strengthening tendons and bones, benefiting Qi                                                                                                               \[[@B19-ijms-18-02172]\]
  Zhuang Yuan Bu Xue Pills           Pericarpium *Zanthoxyli*, Radix *Angelicae Sinensis*, *Colla Corii Asini*, Radix *Morindae Officinalis*, *leopard bone*, Fructus *Psoraleae*, Semen *Plantaginis*, *Halloysitum Rubrum*, Radix *Achyranthis Bidentatae*, Cortex *Lycii*, *Radix Rehmanniae*, Cortex *Eucommiae*, *Poria*                                                            Building fitness, calming nerves, reinforcing the stomach, and curing weak waist, fatigue, insomnia, forgetfulness, poor appetite, and loose stools                                                      \[[@B20-ijms-18-02172]\]
  Hui Chun Jiu                       Pericarpium *Zanthoxyli*, Radix *Angelicae Sinensis*, Rhizoma *Atractylodis*, Cortex *Lycii*, Flos *Caryophylli*, Cortex *Eucommiae*, *Poria*, Radix *Aconiti Lateralis* Preparata, Radix *Glycyrrhizae*, Radix *Aucklandiae*                                                                                                                       Nourishing Yin, tonifying Yang, reinforcing the vital essence, benefiting Qi, nourishing the blood and curing spiritual burnout, weak waist, loss of appetite                                            \[[@B20-ijms-18-02172]\]
  Zhi Chuang Wai Xi Yao              Pericarpium *Zanthoxyli*, Rhizoma *Coptidis*, Radix *Saposhnikoviae*, Radix *Glycyrrhizae*, *Natrii Sulfas*, *Galla Chinensis*, Herba *Houttuyniae*                                                                                                                                                                                                 Removing poison, relieving itching, swelling and pain, and curing hemorrhoids, anal pain, swelling and stiffness                                                                                         \[[@B20-ijms-18-02172]\]
  Ke Tong Ding                       Pericarpium *Zanthoxyli*, *Oleum Menthae*, Radix and *Rhizoma Litseae Cubebae*, Rhizoma *Curcumae*, Rhizoma *Alpiniae Officinarum*, Herba *Pogostemonis*, Radix *Scutellariae*, Lignum *Dalbergiae Odoriferae*                                                                                                                                      Dispelling wind and dampness, promoting blood circulation, alleviating pain, and curing punch injury, rheumatism                                                                                         \[[@B20-ijms-18-02172]\]
  Wen Shen Quan Lu Pills             Pericarpium *Zanthoxyli*, Radix *Angelicae Sinensis*, Rhizoma *Chuanxion*, Flos *Carthami*, Radix *Morindae Officinalis*, Rhizoma *Atractylodis Macrocephalae*, Fructus *Psoraleae*, Lignum *Aquilariae Resinatum*, Pericarpium *Citri Reticulatae*, Radix *Achyranthis Bidentatae*, Radix *Codonopsis*, Radix *Rehmanniae*, Radix *Glycyrrhizae*   Warming the kidneys, reinforcing Qi, nourishing blood, and curing dizziness, forgetful, tinnitus, weak waist, ennui, impotence                                                                           \[[@B20-ijms-18-02172]\]
  Jian Shen Quan Lu pills            Pericarpium *Zanthoxyli*, Radix *Angelicae Sinensis*, Rhizoma *Atractylodis Macrocephalae*, Fructus *Psoraleae*, Lignum *Aquilariae Resinatum*, Pericarpium *Citri Reticulatae*, Rhizoma *Chuanxiong*, Radix *Rehmanniae*, *Poria*, Radix *Glycyrrhizae*, Radix *Astragali*                                                                         Nourishing blood, reinforcing Qi, warming the kidneys, curing weak waist, mental exhaustion caused by blood deficiency                                                                                   \[[@B20-ijms-18-02172]\]
  Chan Ma Zhen Tong Ding             Pericarpium *Zanthoxyli*, Herba *Asari*, *notoginseng* radix and rhizome, *Venenum Bufonis*, Semen *Serychni*, Fructus *Evodiae*, Radix *Aconiti Kusnezoffii*, Folium *Sinapis*, Fructus *Gleditsiae*, *Camphora*                                                                                                                                   Relaxing tendons, activating collaterals, promoting blood circulation, removing blood stasis, and curing paining joints, muscle injury, periathritis of the shoulder, hyperosteogeny                     \[[@B21-ijms-18-02172]\]
  Suan Tong Pen Wu Ji                Pericarpium *Zanthoxyli*, Lignum *Sappan*, Radix *Aconiti Kusnezoffii*, Radix *Aconiti*, Radix *Angelicae Pubescentis*, Rhizoma and Radix *Notopterygii*, Fructus *Liquidambaris*, Fructus *Chaenomelis*, Rhizoma *Arisaematis*, Rhizoma *Pinelliae*                                                                                                Relaxing tendons, activating collaterals, dispelling wind, alleviating pain, and curing sprain, repetitive strain injury, aching muscles                                                                 \[[@B21-ijms-18-02172]\]
  Zhen Tong Huo Luo Ding             Pericarpium *Zanthoxyli*, Radix *Aconiti Kusnezoffii*, Rhizoma *Pinelliae Radix Aconiti*, *Camphora*, Fructus *Gardeniae*, Radix and Rhizoma *Rhei*, Fructus *Chaenomelis*, Rhizoma *Arisaematis*, Rhizoma and Radix *Notopterygii*, Radix *Angelicae Pubescentis*                                                                                  Relaxing tendons, activating collaterals, dispelling wind, alleviating pain, and curing eriathritis of the shoulder, hyperosteogeny, arthritis, cervical spondylopathy                                   \[[@B21-ijms-18-02172]\]
  An Wei Zhi Tong San                Pericarpium *Zanthoxyli*, *Os Sepiae*, Fructus *Foeniculi*, Concha *Margaritifera Usta*, Cortex *Cinnamomi*, Rhizoma *Zingiberis*, Rhizoma *Kaempferiae*, Radix and Rhizoma *Rhei*, Flos *Caryophylli*, Pericarpium *Citri Reticulatae*, *Oleum Menthae*, Radix *Glycyrrhizae*                                                                      Harmonizing the stomach, regulating Qi, relieving pain, and curing epigastric distention, soreness, reflux and acid regurgitation                                                                        \[[@B21-ijms-18-02172]\]
  Hui Sheng Kou Fu Ye                Pericarpium *Zanthoxyli*, Lignum *Sappan*, Herba *Leonuri*, Flos *Carthami*, Radix *Angelicae Sinensis*, Rhizoma *Chuanxion*, *Hirudo*, Rhizoma *Sparganii*, Rhizoma *Anemones Raddeanae*                                                                                                                                                           Removing blood stasis, and curing primary liver cancer, lung cancer                                                                                                                                      \[[@B21-ijms-18-02172]\]
  Fu Fang Zhi Zi Qi Wu Ji            Pericarpium *Zanthoxyli*, Radix *Sophorae Flavescentis*, Fructus *Gardeniae*, Radix *Arnebiae Seu Lithospermi*, Radix *Sanguisorbae*, *Borneolum Syntheticum*, Radix and Rhizoma *Rhei*, Rhizoma *Coptidis*, Flos *Sophorae*, Herba *Asari*                                                                                                         Clearing heat, detoxicating, stopping bleeding, relieving swelling and pain, and curing incising wounds, acne of the superficial skin                                                                    \[[@B21-ijms-18-02172]\]
  Bing Zhi Shang Tong Qi Wu Ding     Pericarpium *Zanthoxyli*, Radix and Rhizoma *Rhei*, Fructus *Gardeniae*, Radix *Rehmanniae*, Lignum *Dalbergiae Odoriferae*, Radix *Allii Tuberosi*, Semen *Serychni*, *Borneolum Syntheticum*, Semen *Persicae*, *Nodus Pini*, Rhizoma *Zingiberis*                                                                                                Clearing heat, detoxicating, cooling the blood, promoting blood circulation, and curing bruises, swelling, and pain caused by extravasated blood, as well as burns                                       \[[@B21-ijms-18-02172]\]
  Zhi Tong An Cha Ji                 Pericarpium *Zanthoxyli*, Radix *Sophorae Flavescentis*, Flos *Lonicerae*, Radix *Rumicis Nepalensis*, Fructus *Aurantii*, Flos *Sophorae*                                                                                                                                                                                                          Clearing heat and wetness, cooling blood and stopping blood, and curing perianalpruritic induced by heat-dampness retention                                                                              \[[@B21-ijms-18-02172]\]
  Li Fu Kang Xi Ji                   Pericarpium *Zanthoxyli*, Radix *Sophorae Flavescentis*, Cortex *Phellodendri*, Fructus *Cnidii*, Cortex *Dictamni*, Rhizoma *Coptidis*, Fructus *Kochiae*, Radix *Isatidis*, Radix *Paeoniae Rubra*, Radix *Polygoni Multiflori*, Rhizoma *Smilacis Glabrae*                                                                                       Clearing heat and wetness, relieving itching, and curing leucorrhea disease, pruritus vulvae, infusorial vulvitis, bacterial vaginopathy                                                                 \[[@B21-ijms-18-02172]\]
  Qing Bai Jie Shen Xi Ye            Pericarpium *Zanthoxyli*, Radix *Angelicae Sinensis*, Radix *Sophorae Flavescentis*, Rhizoma *Coptidis*, Cortex *Phellodendri*, Fructus *Cnidii*, Radix *Astragali*, Radix *Polygoni Multiflori*, Fructus *Kochiae*, Folium *Isatidis*, Radix *Paeoniae Rubra*                                                                                      Clearing heat and wetness, detoxicating, relieving itching, and curing pruritus vulvae, vulvitis, bacterial vaginopathy                                                                                  \[[@B21-ijms-18-02172]\]
  Qu Fu Er Xiang Shuan               Pericarpium *Zanthoxyli*, *Resina Draconis*, *Oblibanum*, Fructus *Cnidii*, *Alumen*, *Borax*, *Realgar*                                                                                                                                                                                                                                            Removing putrid tissues and promoting the growth of new tissue, as well as curing cervical erosion                                                                                                       \[[@B21-ijms-18-02172]\]
  Ku Shen An Shi Jin                 Pericarpium *Zanthoxyli*, Radix *Sophorae Flavescentis*, Herba *Verbenae*, Herba *Taraxaci*, Fructus *Cnidii*, *Galla Chinensis*, Radix *Stemonae*, *Alumen*                                                                                                                                                                                        Clearing heat and wetness, relieving itching, and curing pruritus vulvae in females, scrotal eczema in males                                                                                             \[[@B21-ijms-18-02172]\]
  Ri Shu An Xi Ye                    Pericarpium *Zanthoxyli*, Radix *Sophorae Flavescentis*, Herba *Verbenae*, Herba *Taraxaci*, Fructus *Cnidii*, *Galla Chinensis*, Radix *Stemonae*, *Alumen*                                                                                                                                                                                        Clearing heat and dampness, detoxicating, relieving itching, and curing pruritus vulvae in females, scrotal eczema in males                                                                              \[[@B21-ijms-18-02172]\]

ijms-18-02172-t002_Table 2

###### 

Alkaloids isolated from *Z. bungeanum* (**1**--**35**).

  No.      Name                                                                                                     Part of Plant   Ref.
  -------- -------------------------------------------------------------------------------------------------------- --------------- --------------------------
  **1**    Hydroxy-α-sanshool                                                                                       Pericarps       \[[@B8-ijms-18-02172]\]
  **2**    α-Sanshool                                                                                               Pericarps       \[[@B34-ijms-18-02172]\]
  **3**    Hydroxy-β-sanshool                                                                                       Pericarps       \[[@B8-ijms-18-02172]\]
  **4**    β-Sanshool                                                                                               Pericarps       \[[@B34-ijms-18-02172]\]
  **5**    Hydroxy-γ-sanshool                                                                                       Pericarps       \[[@B8-ijms-18-02172]\]
  **6**    γ-Sanshool                                                                                               Pericarps       \[[@B8-ijms-18-02172]\]
  **7**    (2*E*,4*E*)-2′-Hydroxy-*N*-isobutyl-2,4-tetradecadienamide                                               Pericarps       \[[@B8-ijms-18-02172]\]
  **8**    (2*E*,4*E*, 8*Z*)-2′-Hydroxy-*N*-isobutyl-2,4,8-tetradecatrienamide                                      Pericarps       \[[@B8-ijms-18-02172]\]
  **9**    (2*E*,4*E*,8*Z*,10*E*,12*E*)-l′-Isopropenyl-*N*-(2′-bisobutenyl)-2,4,8,10,12-tetradecapentaenamide       Pericarps       \[[@B8-ijms-18-02172]\]
  **10**   (2*E*,4*E*,8*Z*,11*E*)-2′-Hydroxy-*N*-isobutyl-2,4,8,11-tetradecatetraenamide                            Pericarps       \[[@B8-ijms-18-02172]\]
  **11**   (2*E*,7*E*,9*E*)-*N*-(2-Hydroxy-2-methylpropyl)-6-ethoxy-11-hydroxy-dodeca-2,7,9-trienamide              Pericarps       \[[@B26-ijms-18-02172]\]
  **12**   (2*E*,7*E*,9*E*)-*N*-(2-Hydroxy-2-methylpropyl)-11-ethoxy-6-hydroxy-dodeca-2,7,9-trienamide              Pericarps       \[[@B26-ijms-18-02172]\]
  **13**   (2*E*,6*E*,8*E*)-*N*-(2-Hydroxy-2-methylpropyl)-10-hydroxy-5-oxo-undeca-2,6,8-trienamide                 Pericarps       \[[@B26-ijms-18-02172]\]
  **14**   (2*E*,4*E*,8*E*,10*E*,12*E*)-2′-Hydroxy-*N*-isobutyl-2,4,8,10,12-tetradecatetraenamide                   Pericarps       \[[@B31-ijms-18-02172]\]
  **15**   (2*E*,4*E*,8*E*,10*E*,12*E*)-*N*-Isobutyl-2,4,8,10,12-tetradecapentaenamide                              Pericarps       \[[@B34-ijms-18-02172]\]
  **16**   (2*E*,4*E*,8*Z*,11*Z*)-*N*-(2-Hydroxy-2-methylpropyl)-2,4,8,11-tetradeeatetraenamide                     Pericarps       \[[@B35-ijms-18-02172]\]
  **17**   (2*E*,6*E*,8*E*)-*N*-(2-Hydroxy-2-methylpropyl)-10-oxo-2,6,8-decatrienamide                              Pericarps       \[[@B35-ijms-18-02172]\]
  **18**   2′-Hydroxy-*N*-isobytyl-\[*trans*-2,6,8,10\] dodecatetraenamide                                          Pericarps       \[[@B34-ijms-18-02172]\]
  **19**   (6*RS*)-(2*E*,7*E*,9*E*)-6-Hydroxy-*N*-(2-hydroxy-2-methylpropyl)-11-oxo-2,7,9-dodecatrienamide          Pericarps       \[[@B36-ijms-18-02172]\]
  **20**   *N*-\[2-(3,4-Dimethoxyphenyl)ethyl\]-3-phenyl-acrylamide                                                 Pericarps       \[[@B37-ijms-18-02172]\]
  **21**   Bugeanumamide A                                                                                          Pericarps       \[[@B38-ijms-18-02172]\]
  **22**   (11*RS*)-(2*E*,7*E*,9*E*)-11-Hydroxy-*N*-(2-hydroxy-2-methylpropyl)-6-oxo-2,7,9-dodecatrienamide         Pericarps       \[[@B38-ijms-18-02172]\]
  **23**   (10*RS*,11*RS*)-(2*E*,6*Z*,8*E*)-10,11-Dihydroxy-*N*-(2-hydroxy-2-methylpropyl)-2,6,8-dodecatrienamide   Pericarps       \[[@B38-ijms-18-02172]\]
  **24**   (6*RS*,11*RS*)-(2*E*,7*E*,9*E*)-*N*-(2-Hydroxy-2-methylpropyl)-6,11-dioxo-2,7,9-dodecatrienamide         Pericarps       \[[@B38-ijms-18-02172]\]
  **25**   (2*E*,4*E*,9*E*,11*E*)-*N*-(2-Hydroxy-2-methypropyl)-8-hydroxy-13-oxo-2,4,9,11-tetradecatetraenamide     Pericarps       \[[@B38-ijms-18-02172]\]
  **26**   (2*E*,4*E*,9*E*,11*E*)-*N*-(Hydroxy-2-methypropyl)-8,13-dihydroxy-2,4,9,11-tetradecatetraenamide         Pericarps       \[[@B38-ijms-18-02172]\]
  **27**   (2*E*)-6,6-Dimethoxy-*N*-(2-hydroxy-2-methylpropyl)-2-hexenamide                                         Pericarps       \[[@B37-ijms-18-02172]\]
  **28**   Zanthobungeanine                                                                                         Roots           \[[@B32-ijms-18-02172]\]
  **29**   Demethoxy chelerythrine                                                                                  Roots           \[[@B32-ijms-18-02172]\]
  **30**   11-Demethoxy chelerythrine                                                                               Roots           \[[@B32-ijms-18-02172]\]
  **31**   [l]{.smallcaps}-*N*-Acetylanonanine                                                                      Roots           \[[@B32-ijms-18-02172]\]
  **32**   Arnothianamide                                                                                           Roots           \[[@B32-ijms-18-02172]\]
  **33**   Skimmianine                                                                                              Pericarps       \[[@B32-ijms-18-02172]\]
  **34**   Haplopine                                                                                                Pericarps       \[[@B33-ijms-18-02172]\]
  **35**   Kokusaginine                                                                                             Pericarps       \[[@B33-ijms-18-02172]\]

Alkaloids isolated from *Z. bungeanum*.

ijms-18-02172-t003_Table 3

###### 

Terpenoids isolated from *Z. bungeanum* (**36**--**103**).

  No.       Name                                     Part of Plant   Ref.
  --------- ---------------------------------------- --------------- --------------------------
  **36**    Linalool                                 Pericarps       \[[@B9-ijms-18-02172]\]
  **37**    Limonene                                 Pericarps       \[[@B9-ijms-18-02172]\]
  **38**    Geraniol                                 Pericarps       \[[@B9-ijms-18-02172]\]
  **30**    *p*-Mentha-1,3,8-triene                  Pericarps       \[[@B9-ijms-18-02172]\]
  **40**    Citronellal                              Pericarps       \[[@B9-ijms-18-02172]\]
  **41**    Isopulegol                               Pericarps       \[[@B9-ijms-18-02172]\]
  **42**    Hotrienol                                Pericarps       \[[@B9-ijms-18-02172]\]
  **43**    4-Terpinenyl acetate                     Pericarps       \[[@B9-ijms-18-02172]\]
  **44**    *cis*-*p*-2-Menthen-1-ol                 Pericarps       \[[@B9-ijms-18-02172]\]
  **45**    *cis*-*p*-Mentha-2,8-dien-1-ol           Pericarps       \[[@B9-ijms-18-02172]\]
  **46**    Citronellyl acetate                      Pericarps       \[[@B9-ijms-18-02172]\]
  **47**    *trans*-*p*-Mentha-2,8-dienol            Pericarps       \[[@B9-ijms-18-02172]\]
  **48**    *p*-Mentha-1,8-dien-4-ol                 Pericarps       \[[@B9-ijms-18-02172]\]
  **49**    Cryptone                                 Pericarps       \[[@B9-ijms-18-02172]\]
  **50**    *trans*-Piperitol                        Pericarps       \[[@B9-ijms-18-02172]\]
  **51**    *cis*-Carveyl acetate                    Pericarps       \[[@B9-ijms-18-02172]\]
  **52**    *p*-Menth-1-en-9-al                      Pericarps       \[[@B9-ijms-18-02172]\]
  **53**    *trans*-Carveol                          Pericarps       \[[@B9-ijms-18-02172]\]
  **54**    *p*-Mentha-1,8(10)-dien-9-ol             Pericarps       \[[@B9-ijms-18-02172]\]
  **55**    Isopiperitenone                          Pericarps       \[[@B9-ijms-18-02172]\]
  **56**    *p*-1,8-Menthadienyl-7 acetate           Pericarps       \[[@B9-ijms-18-02172]\]
  **57**    2,3-Dehydro-1,8-cineole                  Pericarps       \[[@B9-ijms-18-02172]\]
  **58**    *trans*-Sabinene hydrate                 Pericarps       \[[@B9-ijms-18-02172]\]
  **59**    *trans*-Sabinene hydrate acetate         Pericarps       \[[@B9-ijms-18-02172]\]
  **60**    Pinocarvone                              Pericarps       \[[@B9-ijms-18-02172]\]
  **61**    Bornyl acetate                           Pericarps       \[[@B9-ijms-18-02172]\]
  **62**    Myrtenal                                 Pericarps       \[[@B9-ijms-18-02172]\]
  **63**    *trans*-Pinocarveol                      Pericarps       \[[@B9-ijms-18-02172]\]
  **64**    Myrtenol                                 Pericarps       \[[@B9-ijms-18-02172]\]
  **65**    α-Cubebene                               Pericarps       \[[@B9-ijms-18-02172]\]
  **66**    α-Bergamotene                            Pericarps       \[[@B9-ijms-18-02172]\]
  **67**    Germacrene B                             Pericarps       \[[@B9-ijms-18-02172]\]
  **68**    γ-Cadinene                               Pericarps       \[[@B9-ijms-18-02172]\]
  **69**    α-Calacorene                             Pericarps       \[[@B9-ijms-18-02172]\]
  **70**    β-Terpineol                              Pericarps       \[[@B39-ijms-18-02172]\]
  **71**    α-Terpineol                              Pericarps       \[[@B40-ijms-18-02172]\]
  **72**    α-Terpinene                              Pericarps       \[[@B40-ijms-18-02172]\]
  **73**    p-Cymene                                 Pericarps       \[[@B40-ijms-18-02172]\]
  **74**    Neryl acetate                            Pericarps       \[[@B9-ijms-18-02172]\]
  **75**    Geranyl acetate                          Pericarps       \[[@B9-ijms-18-02172]\]
  **76**    Carvone                                  Pericarps       \[[@B9-ijms-18-02172]\]
  **77**    β-Thujone                                Pericarps       \[[@B9-ijms-18-02172]\]
  **78**    β-Myrcene                                pericarps       \[[@B9-ijms-18-02172]\]
  **79**    *cis*-Carveol                            Pericarps       \[[@B9-ijms-18-02172]\]
  **80**    4-Isopropyl-l-methyl-2-cyclohexen-l-ol   Seeds           \[[@B9-ijms-18-02172]\]
  **81**    Linalyl anthranilate                     Pericarps       \[[@B41-ijms-18-02172]\]
  **82**    Caryophyllene oxide                      pericarps       \[[@B41-ijms-18-02172]\]
  **83**    Germacrene D                             Pericarps       \[[@B41-ijms-18-02172]\]
  **84**    Nerol                                    Pericarps       \[[@B41-ijms-18-02172]\]
  **85**    Eucalyptol                               Pericarps       \[[@B41-ijms-18-02172]\]
  **86**    24-en-Cycloartenone                      Seeds           \[[@B42-ijms-18-02172]\]
  **87**    Camphene                                 Pericarps       \[[@B43-ijms-18-02172]\]
  **88**    β-Caryophyllene                          Pericarps       \[[@B43-ijms-18-02172]\]
  **89**    α-Cadinol                                Pericarps       \[[@B43-ijms-18-02172]\]
  **90**    β-Elemene                                Pericarps       \[[@B43-ijms-18-02172]\]
  **91**    Myrcene                                  Pericarps       \[[@B43-ijms-18-02172]\]
  **92**    Carvacrol                                Pericarps       \[[@B43-ijms-18-02172]\]
  **93**    (*E*)-β-Ocimene                          Pericarps       \[[@B43-ijms-18-02172]\]
  **94**    (*Z*)-β-Ocimene                          Pericarps       \[[@B43-ijms-18-02172]\]
  **95**    Sabinene                                 Pericarps       \[[@B43-ijms-18-02172]\]
  **96**    *α*-Terpinyl acetate                     Pericarps       \[[@B43-ijms-18-02172]\]
  **97**    Piperitone                               Pericarps       \[[@B43-ijms-18-02172]\]
  **98**    α-Thujene                                Pericarps       \[[@B43-ijms-18-02172]\]
  **99**    β-Pinene                                 Pericarps       \[[@B44-ijms-18-02172]\]
  **100**   β-Phellandrene                           Pericarps       \[[@B45-ijms-18-02172]\]
  **101**   γ-Terpinene                              Pericarps       \[[@B45-ijms-18-02172]\]
  **102**   α-Pinene                                 pericarps       \[[@B45-ijms-18-02172]\]
  **103**   Terpinolene                              Pericarps       \[[@B45-ijms-18-02172]\]

Terpenoids isolated from *Z. bungeanum*.
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###### 

Flavonoids isolated from *Z. bungeanum* (**104**--**129**).

  No.       Name                                              Part of Plant   Ref.
  --------- ------------------------------------------------- --------------- --------------------------
  **104**   Rutin                                             Leaves          \[[@B10-ijms-18-02172]\]
  **105**   Syringetin-3-glucoside                            Leaves          \[[@B10-ijms-18-02172]\]
  **106**   Isorhamnetin-3-glucoside                          Leaves          \[[@B10-ijms-18-02172]\]
  **107**   Quercetin 3-arabinoside                           Pericarps       \[[@B10-ijms-18-02172]\]
  **108**   3,5,7,3′,4′-Pentahydroxyflavone                   Leaves          \[[@B23-ijms-18-02172]\]
  **109**   Quercetin 3-*O*-α-[l]{.smallcaps}-rhamnoside      Leaves          \[[@B23-ijms-18-02172]\]
  **110**   Quercetin 3-*O*-β-[d]{.smallcaps}-glucoside       Leaves          \[[@B23-ijms-18-02172]\]
  **111**   Trifolin                                          Leaves          \[[@B23-ijms-18-02172]\]
  **112**   Quercetin 3-*O*-β-[d]{.smallcaps}-galactoside     Leaves          \[[@B23-ijms-18-02172]\]
  **113**   Kaempferol 3-*O*-α-[l]{.smallcaps}-rhamnoside     Leaves          \[[@B23-ijms-18-02172]\]
  **114**   Isorhamnetin 3-*O*-α-[l]{.smallcaps}-rhamnoside   Leaves          \[[@B23-ijms-18-02172]\]
  **115**   Kaempferol-7-rhamnoside                           Leaves          \[[@B10-ijms-18-02172]\]
  **116**   Apigenin-8-*C*-glucoside                          Leaves          \[[@B10-ijms-18-02172]\]
  **117**   Apigenin-8-*C*-arabinoside                        Leaves          \[[@B10-ijms-18-02172]\]
  **118**   Quercetin-3-rutinoside-7-rhamnoside               Leaves          \[[@B10-ijms-18-02172]\]
  **119**   Kaempferol-3-rutinoside                           Leaves          \[[@B10-ijms-18-02172]\]
  **120**   Quercetin 3′,4′-dimethyl ether 7-glucoside        Pericarps       \[[@B46-ijms-18-02172]\]
  **121**   Tamarixetin 3,7-bis-glucoside                     Pericarps       \[[@B46-ijms-18-02172]\]
  **122**   Isorhamnetin 7-glucoside                          Pericarps       \[[@B46-ijms-18-02172]\]
  **123**   3,5,6-Trihydroxy-7,4′-dimethoxy flavone           Pericarps       \[[@B46-ijms-18-02172]\]
  **124**   5-Feruloyquinic acid                              Leaves          \[[@B10-ijms-18-02172]\]
  **125**   Chlorogenic acid                                  Leaves          \[[@B10-ijms-18-02172]\]
  **126**   Sitosterol β-glucoside                            Pericarps       \[[@B46-ijms-18-02172]\]
  **127**   [l]{.smallcaps}-sesamin                           Pericarps       \[[@B46-ijms-18-02172]\]
  **128**   Quinic acid                                       Leaves          \[[@B10-ijms-18-02172]\]
  **129**   Epicatechin                                       Leaves          \[[@B10-ijms-18-02172]\]

Flavonoids isolated from *Z. bungeanum*.
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###### 

Fatty acids isolated from *Z. bungeanum* (**130**--**139**).

  No.       Name                 Part of Plant   Ref.
  --------- -------------------- --------------- --------------------------
  **130**   Nonanoic acid        Pericarps       \[[@B49-ijms-18-02172]\]
  **131**   Tetradecanoic acid   Seeds           \[[@B11-ijms-18-02172]\]
  **132**   Pentadecanoic acid   Seeds           \[[@B11-ijms-18-02172]\]
  **133**   Hexadecanoic acid    Seeds           \[[@B11-ijms-18-02172]\]
  **134**   Stearic acid         Seeds           \[[@B11-ijms-18-02172]\]
  **135**   Eicosoic acid        Seeds           \[[@B11-ijms-18-02172]\]
  **136**   Oleic acid           Seeds           \[[@B11-ijms-18-02172]\]
  **137**   Palmitoleic acid     Seeds           \[[@B49-ijms-18-02172]\]
  **138**   Linolenic acid       Seeds           \[[@B48-ijms-18-02172]\]
  **139**   Linoleic acid        Seeds           \[[@B48-ijms-18-02172]\]

Fatty acids isolated from *Z. bungeanum*.
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###### 

Other chemical compounds isolated from *Z. bungeanum* (**140**--**149**).

  No.       Name                             Part of Plant   Ref.
  --------- -------------------------------- --------------- --------------------------
  **140**   Rosefuran                        Pericarps       \[[@B9-ijms-18-02172]\]
  **141**   Myrcene epoxide                  Pericarps       \[[@B9-ijms-18-02172]\]
  **142**   Perillene                        Pericarps       \[[@B9-ijms-18-02172]\]
  **143**   Vanillic acid-4-glucoside        Leaves          \[[@B10-ijms-18-02172]\]
  **144**   β-Sitosterol                     Roots           \[[@B32-ijms-18-02172]\]
  **145**   Daucosterol                      Seeds           \[[@B47-ijms-18-02172]\]
  **146**   Isoimperatorin                   Seeds           \[[@B47-ijms-18-02172]\]
  **147**   Methyl-4-hydroxyphenylacrylate   Pericarps       \[[@B50-ijms-18-02172]\]
  **148**   7-Methoxycoumarin                Pericarps       \[[@B50-ijms-18-02172]\]
  **149**   Xanthoxylin                      Pericarps       \[[@B50-ijms-18-02172]\]

Other chemical compounds isolated from *Z. bungeanum.*
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###### 

Pharmacological effects of *Z. bungeanum*.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Pharmacological Effects                                                                                                                                                                                                                 Detail                                                                                                                                        Extracts/Compounds                                                                                                                                   Minimal Active Concentration/Dose                                                     In Vitro/In Vivo                                Ref.
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ----------------------------------------------- -----------------------------------------------
                                                                                                                                                                                                                                          Regulation on gastrointestinal smooth muscle                                                                                                  WEZB                                                                                                                                                 4.0 and 12 mg/mL (i.g.)                                                               in vivo                                         \[[@B51-ijms-18-02172],[@B52-ijms-18-02172]\]

  Effect on the digestive system                                                                                                                                                                                                          Anti-ulcer effects                                                                                                                            Water extracts of *Z. bungeanum* (WEZB)                                                                                                              2.5, 5, and 10 g/kg (i.g.(intragastric administration), crude herb mass equivalent)   in vivo                                         \[[@B53-ijms-18-02172]\]

  Anti-diarrhea effects                                                                                                                                                                                                                   PEZB                                                                                                                                          3.0 and 6.0 mL/kg (i.g.)                                                                                                                             in vivo                                                                               \[[@B53-ijms-18-02172]\]                        

  WEZB                                                                                                                                                                                                                                    5 and 10 g/kg (i.g., crude herb mass equivalent)                                                                                              in vivo                                                                                                                                              \[[@B53-ijms-18-02172]\]                                                                                                              

  Inhibiting contraction of isolated duodenal smooth muscle                                                                                                                                                                               EOZB                                                                                                                                          0.1 mg/mL                                                                                                                                            in vitro                                                                              \[[@B54-ijms-18-02172]\]                        

  Inhibiting contraction of isolated colon smooth muscle                                                                                                                                                                                  EOZB                                                                                                                                          0.4 g/L (i.g.)                                                                                                                                       in vivo                                                                               \[[@B55-ijms-18-02172]\]                        

  Alleviating DSS-induced experimental colitis                                                                                                                                                                                            WEZB                                                                                                                                          0.5,1.0, and 2.0 g/kg (i.g., for 14 days)                                                                                                            in vivo                                                                               \[[@B56-ijms-18-02172]\]                        

  Accelerating defecation                                                                                                                                                                                                                 Hydroxy-α-sanshool (HAS)                                                                                                                      50 mg/kg (per os (p.o.), crude herb mass equivalent)                                                                                                 in vivo                                                                               \[[@B57-ijms-18-02172]\]                        

  Improving blood flow of the colon                                                                                                                                                                                                       HAS                                                                                                                                           0.3 mg/kg                                                                                                                                            in vivo                                                                               \[[@B57-ijms-18-02172]\]                        

  Improving release of ADM from intestinal epithelial cells                                                                                                                                                                               HAS                                                                                                                                           0.3, 10, and 30 μmol/L                                                                                                                               in vitro                                                                              \[[@B57-ijms-18-02172]\]                        

  Enhancing long distance contraction of the proximal colon                                                                                                                                                                               HAS                                                                                                                                           3, 10, and 30 μM                                                                                                                                     in vitro                                                                              \[[@B58-ijms-18-02172]\]                        

  Effect on the nervous system                                                                                                                                                                                                            Blocking nerve impulse                                                                                                                        Essential oils of *Z. bungeanum* (EOZB) and WEZB                                                                                                     20%                                                                                   in vitro                                        \[[@B59-ijms-18-02172],[@B60-ijms-18-02172]\]

  Anti-depressive effects on behavioral despair models                                                                                                                                                                                    PEZB                                                                                                                                          50 mg/kg (i.g.)                                                                                                                                      in vivo                                                                               \[[@B61-ijms-18-02172]\]                        

  Reducing time of tail suspension                                                                                                                                                                                                        PEZB                                                                                                                                          50 mg/kg (i.g., for 21 days)                                                                                                                         in vivo                                                                               \[[@B62-ijms-18-02172]\]                        

  Upregulate NE and 5-HT                                                                                                                                                                                                                  PEZB                                                                                                                                          50 mg/kg (i.g., for 21 days)                                                                                                                         in vivo                                                                               \[[@B63-ijms-18-02172]\]                        

  Anti-depressive effects in the unpredictable stress model and ovariectomized model                                                                                                                                                      PEZB                                                                                                                                          50 mg/kg (i.g., for 21 days)                                                                                                                         in vivo                                                                               \[[@B64-ijms-18-02172],[@B65-ijms-18-02172]\]   

  Shorten the escape latency in mice                                                                                                                                                                                                      HAS                                                                                                                                           5 mg/kg (p.o.)                                                                                                                                       in vitro                                                                              \[[@B66-ijms-18-02172]\]                        

  Inhibiting Aβ-induced neuronal apoptosis and reducing neuronal toxicity                                                                                                                                                                 gx-50                                                                                                                                         5 μM                                                                                                                                                 in vitro                                                                              \[[@B37-ijms-18-02172]\]                        

  Enhancing the cross-platform times                                                                                                                                                                                                      gx-50                                                                                                                                         1 mg/kg(i.p., for 2 months)                                                                                                                          in vivo                                                                               \[[@B37-ijms-18-02172]\]                        

  Inhibiting cytokine release                                                                                                                                                                                                             gx-50                                                                                                                                         500 μM                                                                                                                                               in vitro                                                                              \[[@B67-ijms-18-02172]\]                        

  Enhancing neurite outgrowth                                                                                                                                                                                                             *Z. bungeanum* (ZP)-amide A, ZP-amide B, ZP-amide C                                                                                           20 μM                                                                                                                                                in vitro                                                                              \[[@B26-ijms-18-02172]\]                        

  Effect on the circulatory system                                                                                                                                                                                                        Reducing CHOL, TG, LDL, increasing HDL-C                                                                                                      Seed oil of *Z. bungeanum* (SOZB)                                                                                                                    5, 10, and 20 mL/kg (i.g., for 4 weeks)                                               in vivo                                         \[[@B68-ijms-18-02172]\]

  Reducing HBV, HLV, CHOL, TG and increasing HDL-C                                                                                                                                                                                        SOZB                                                                                                                                          2.5 mL/kg (i.g., for 10 weeks)                                                                                                                       in vivo                                                                               \[[@B69-ijms-18-02172]\]                        

  Reducing TG, TC, LDL-C, MDA, and NO                                                                                                                                                                                                     SOZB                                                                                                                                          2.5, 5, and 10 g/kg (i.g., for 30 days)                                                                                                              in vivo                                                                               \[[@B70-ijms-18-02172]\]                        

  Relaxing contracted aortic muscle                                                                                                                                                                                                       EOZB                                                                                                                                          2.0, 4.0, 6.0, 8.0, and 10.0 μL/mL                                                                                                                   In vitro                                                                              \[[@B71-ijms-18-02172]\]                        

  Increased the survival rate of mice subjected to collagen-adrenaline                                                                                                                                                                    (Alpha-linolenic acid) ALA                                                                                                                    250 mg/kg (p.o., for 10 days)                                                                                                                        in vivo                                                                               \[[@B72-ijms-18-02172]\]                        

  Prolonged hemorrhage and coagulation time                                                                                                                                                                                               ALA and its mixture                                                                                                                           50, 100, and 250 mg/kg (p.o., for 10 days)                                                                                                           in vivo                                                                               \[[@B72-ijms-18-02172]\]                        

  Decreased platelet aggregation                                                                                                                                                                                                          ALA and its mixture                                                                                                                           70 and 175 mg/kg (p.o., for 10 days)                                                                                                                 in vivo                                                                               \[[@B72-ijms-18-02172]\]                        

  Anti-inflammatory and analgesic effects                                                                                                                                                                                                 Inhibiting dimethylbenzene-induced ear oedema, carrageenan-induced rat paw oedema and acetic acid-induced torsion                             WEZB                                                                                                                                                 2.5, 5.0, and 10 g/kg\                                                                in vivo                                         \[[@B73-ijms-18-02172]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             (i.g., for 3 days, crude herb mass equivalent)                                                                                        

  DEZB                                                                                                                                                                                                                                    1.5, 3.0, and 6.0 mL/kg (i.g.)                                                                                                                in vivo                                                                                                                                              \[[@B73-ijms-18-02172]\]                                                                                                              

  Inhibiting dimethylbenzene-induced oedema ear, acetic acid-induced pain                                                                                                                                                                 EOZB                                                                                                                                          0.05, 0.1, and 0.2 g/kg (i.g., for 14 days)                                                                                                          in vivo                                                                               \[[@B74-ijms-18-02172]\]                        

  Inhibiting hot-plate-induced pain and dextran-40-induced itch--scratch responses                                                                                                                                                        Alkaloids of *Z. bungeanum* (AZB)                                                                                                             118, 236, and 472 mg/kg (i.g., for 3 days)                                                                                                           in vivo                                                                               \[[@B75-ijms-18-02172]\]                        

  Inhibiting NO production                                                                                                                                                                                                                MEZB                                                                                                                                          200 μM                                                                                                                                               in vitro                                                                              \[[@B76-ijms-18-02172]\]                        

  Inhibiting iNOS mRNA expression                                                                                                                                                                                                         4-*O*-β-[d]{.smallcaps}-Glucopyranosyldihydroferulic acid                                                                                     IC~50~ = 6.5 μg/mL                                                                                                                                   in vitro                                                                              \[[@B76-ijms-18-02172]\]                        

  Analgesic effect on formalin test                                                                                                                                                                                                       EEZB, MEZB                                                                                                                                    40 μL, 5% (i.p.)                                                                                                                                     in vivo                                                                               \[[@B77-ijms-18-02172]\]                        

  Relieving pain on tail-flick test                                                                                                                                                                                                       EEZB                                                                                                                                          20 μL, 5% (i.p.)                                                                                                                                     in vivo                                                                               \[[@B77-ijms-18-02172]\]                        

  Inhibiting the excitability of A*δ* mechanosensory nociceptors                                                                                                                                                                          HAS                                                                                                                                           IC~50~ = 70 ± 7 μM                                                                                                                                   in vitro                                                                              \[[@B78-ijms-18-02172]\]                        

  Inhibiting effects on nitric oxide (NO) production in LPS-stimulated RAW 264.7 macrophages                                                                                                                                              ZP-amide D, ZP-amide E,\                                                                                                                      IC~50~ = 48.7 ± 0.32, 27.1 ± 1.15, 49.8 ± 0.38, and\                                                                                                 in vitro                                                                              \[[@B38-ijms-18-02172]\]                        
                                                                                                                                                                                                                                          ZP-amide F and ZP-amide G                                                                                                                     39.4 ± 0.63 μM, respectively                                                                                                                                                                                                                                                               

  Antioxidant effect                                                                                                                                                                                                                      Reducing MDA                                                                                                                                  WEZB                                                                                                                                                 0.0195, 0.039, and 0.156 mg/mL                                                        in vitro                                        \[[@B79-ijms-18-02172]\]

  Scavenging DPPH radicals                                                                                                                                                                                                                FWEZBL, FEEZBL and FAEZBL                                                                                                                     IC~50~ = 24, 17.5, and 7.6 μg/mL, respectively                                                                                                       in vitro                                                                              \[[@B80-ijms-18-02172]\]                        

  SOZB                                                                                                                                                                                                                                    Not mentioned                                                                                                                                 in vitro                                                                                                                                             \[[@B11-ijms-18-02172]\]                                                                                                              

  EEZBL, EAEEZBL, AEEZBL and MEEZBL                                                                                                                                                                                                       IC~50~ = 40.75 ± 0.21, 13.20 ± 0.85, 18.55 ± 0.35 and\                                                                                        in vitro                                                                                                                                             \[[@B23-ijms-18-02172],[@B81-ijms-18-02172]\]                                                                                         
                                                                                                                                                                                                                                          85.85 ± 2.19 μg/mL, respectively                                                                                                                                                                                                                                                                                                                                                                                                         

  Polysaccharide of *Z. bungeanum* (PZB)                                                                                                                                                                                                  EC~50~ = 0.021 mg/mL                                                                                                                          in vitro                                                                                                                                             \[[@B82-ijms-18-02172]\]                                                                                                              

  Three fractions (\<10 kDa, 10\~30 kDa, and \>30 kDa) of polypeptide of *Z. bungeanum* seeds kernel (PZBSK)                                                                                                                              10 mg/mL                                                                                                                                      in vitro                                                                                                                                             \[[@B83-ijms-18-02172]\]                                                                                                              

  Quercetin, Quercitrin, Quercetin-3-*O*-β-[d]{.smallcaps}-glucoside, Hyperoside, Rutin and Isorhamnetin 3-*O*-α-[l]{.smallcaps}-rhamnoside                                                                                               IC~50~ = 0.009 ± 0.001, 0.011 ± 0.001, 0.012 ± 0.001, 0.011 ± 0.001, 0.016 ± 0.001, and 0.028 ± 0.001 mM, respectively                        in vitro                                                                                                                                             \[[@B23-ijms-18-02172]\]                                                                                                              

  Reducing ferric and ABTS^+^ radical                                                                                                                                                                                                     AEEZBL                                                                                                                                        615.88 ± 1.86 and 2147.83 ± 23.08 μmol equiv. Trolox/g, respectively                                                                                 in vitro                                                                              \[[@B23-ijms-18-02172],[@B81-ijms-18-02172]\]   

  Reducing Fe^3+^                                                                                                                                                                                                                         PZB                                                                                                                                           EC~50~ = 0.011 mg/mL                                                                                                                                 in vitro                                                                              \[[@B82-ijms-18-02172]\]                        

  Reducing hydroxyl radical                                                                                                                                                                                                               PZB                                                                                                                                           EC~50~ = 0.008 mg/mL                                                                                                                                 in vitro                                                                              \[[@B82-ijms-18-02172]\]                        

  Chelating Fe^2+^                                                                                                                                                                                                                        PZB                                                                                                                                           EC~50~ = 0.056 mg/mL                                                                                                                                 in vitro                                                                              \[[@B82-ijms-18-02172]\]                        

  Decreased hexanal content, TBARS value, and LOX                                                                                                                                                                                         EEZBL                                                                                                                                         0.015%, 0.030%, and 0.045%, for 8 days                                                                                                               in vitro                                                                              \[[@B25-ijms-18-02172]\]                        

  Increased catalase, superoxide dismutase, and glutathione peroxidase activities, decreased PV TBARS values                                                                                                                              EEZBL                                                                                                                                         0.018%                                                                                                                                               in vitro                                                                              \[[@B84-ijms-18-02172]\]                        

  Chlorogenic acid, Hyperoside and Quercitrin                                                                                                                                                                                             0.01%                                                                                                                                         in vitro                                                                                                                                             \[[@B84-ijms-18-02172]\]                                                                                                              

  Increased cell growth rate of *E. coli*                                                                                                                                                                                                 Quercetin, Quercitrin, Quercetin-3-*O*-β-[d]{.smallcaps}-glucoside, Hyperoside, rutin and Isorhamnetin 3-*O*-*α*-[l]{.smallcaps}-Rhamnoside   Not mentioned                                                                                                                                        in vitro                                                                              \[[@B22-ijms-18-02172]\]                        

  Inhibitory capacity on lipid peroxidation                                                                                                                                                                                               Vitexin, Quercitrin, Afzelin, Trifolin                                                                                                        IC~50~ = 0.014 ± 0.001 0.013 ± 0.005, 0.065 ± 0.003, and\                                                                                            in vitro                                                                              \[[@B23-ijms-18-02172]\]                        
                                                                                                                                                                                                                                                                                                                                                                                        0.040 ± 0.001 mM, respectively                                                                                                                                                                                                                                                             

  Anti-tumor effect                                                                                                                                                                                                                       Anti-tumor effects on H~22~                                                                                                                   EOZB                                                                                                                                                 4 mg/mL                                                                               in vitro                                        \[[@B85-ijms-18-02172]\]

  Inhibitory effects on the growth of tumor in mice                                                                                                                                                                                       EOZB                                                                                                                                          10, 25, 50, and 100 mg/kg                                                                                                                            in vivo                                                                               \[[@B85-ijms-18-02172]\]                        

  Anti-tumor effects on HeLa, A549, k562                                                                                                                                                                                                  EOZB                                                                                                                                          IC~50~ = 11.2 ± 0.2, 6.26 ± 0.05 and 1.37 ± 0.03 mg/mL, respectively                                                                                 in vitro                                                                              \[[@B86-ijms-18-02172],[@B87-ijms-18-02172]\]   

  Anti-tumor effects on PC~12~                                                                                                                                                                                                            EOZB                                                                                                                                          0.5 mg/mL\~2.0 mg/mL                                                                                                                                 in vitro                                                                              \[[@B86-ijms-18-02172],[@B87-ijms-18-02172]\]   

  Anti-proliferative effect towards HaCaT                                                                                                                                                                                                 EOZB                                                                                                                                          IC~50~ = 0.024% (*v*/*v*, for 48 h)                                                                                                                  in vitro                                                                              \[[@B88-ijms-18-02172]\]                        

  Inhibiting PC-3 cells, HEp-2 cells, Hela cells, MFC-7 cells                                                                                                                                                                             EOZB                                                                                                                                          IC~50~ = 0.04%, 0.021%, 0.03%, and 0.023%, respectively                                                                                              in vitro                                                                              \[[@B88-ijms-18-02172]\]                        

  Anti-proliferation effects against HepG2 cells                                                                                                                                                                                          Sanshools                                                                                                                                     0\~250 μg/mL                                                                                                                                         in vitro                                                                              \[[@B89-ijms-18-02172],[@B90-ijms-18-02172]\]   

  Inducting apoptosis activity against HepG2 cells                                                                                                                                                                                        Sanshools                                                                                                                                     (0\~200 μg/mL)                                                                                                                                       in vitro                                                                              \[[@B89-ijms-18-02172],[@B90-ijms-18-02172]\]   

  Inducing apoptosis and inhibiting cell growth in HepG2 cells                                                                                                                                                                            EEZB                                                                                                                                          1 μg/mL\~8 μg/mL(for 48 h)                                                                                                                           in vitro                                                                              \[[@B91-ijms-18-02172]\]                        

  Inhibitory effects against *SW620* cell                                                                                                                                                                                                 Hyperoside                                                                                                                                    IC~50~ = 19.51 ± 4.95 μM for 96 h                                                                                                                    in vitro                                                                              \[[@B92-ijms-18-02172]\]                        

  Inhibiting proliferation of HaCaT cells                                                                                                                                                                                                 [d]{.smallcaps}-Limonene, Terpinen-4-ol and β-Myrcene                                                                                         IC~50~ = 0.009%, 0.028%, 0.013% (*v*/*v*, for 48 h), respectively                                                                                    in vitro                                                                              \[[@B88-ijms-18-02172]\]                        

  Anti-bacterial and anti-fungal effects                                                                                                                                                                                                  Decreased viable count of *S. aureus* and *E. coli*                                                                                           WEZB                                                                                                                                                 5 mg/mL (for 4 days, crude herb mass equivalent)                                      in vitro                                        \[[@B79-ijms-18-02172]\]

  Inhibitory effects against *Alternariasolani*, *B. theobromae*, *F. oxysporum* f.sp. *cucumerinum*, *F. oxysporum* f.sp. *niverum*, *B. maydis*, *L. maculans*, *M. grisea*, *R. cerealis*, *R. solani*, *V. Pirina*, and *V. dahlia*   EOZB                                                                                                                                          IC~50~ = 0.44, 0.48, 0.43, 0.48, 0.24, 0.13, 0.28, 0.27, 0.24, 0.41, and 0.32 mg/mL, respectively                                                    in vitro                                                                              \[[@B43-ijms-18-02172]\]                        

  Inhibiting the growth of *R. solani* and *R. cerealis* mycelia                                                                                                                                                                          EOZB                                                                                                                                          IC~50~ = 0.95 and 1.22 mg/mL, respectively                                                                                                           in vitro                                                                              \[[@B43-ijms-18-02172]\]                        

  Inhibitory effects towards *B. subtilis*, *Salmonella*, *S.aureus*, *B. cereus*, *E. coli*, *P. vulgaris*, *P. Crtinum Thom*, *A. flavus*, *A. niger*, *R. Nigricans*, and *S.cerevisiae*                                               EOZB                                                                                                                                          Minimum bacteriacidal (or fungicidal) (MIC/MFC) concentrations = 25, 6.25, 25, 12.5, 12.5, 12.5, 12.5, 12.5, 12.5, 25, and 12.5 mL/L, respectively   in vitro                                                                              \[[@B93-ijms-18-02172]\]                        

  Inhibiting food-borne bacteria *S. aureus*, *B. subtilis*, *B. cereus*, *B. Laubach*, and *E. coli*                                                                                                                                     EOZB                                                                                                                                          MIC = 5.0, 1.25, 2.5, 1.25, and 2.5 mg/mL, respectively.\                                                                                            in vitro                                                                              \[[@B44-ijms-18-02172]\]                        
                                                                                                                                                                                                                                                                                                                                                                                        MBC = 20, 2.5, 10, 5.0, and 5.0 mg/mL, respectively                                                                                                                                                                                                                                        

  Inhibitory effects against *F. sulphureum*                                                                                                                                                                                              EOZB and *α*-Pinene                                                                                                                           MIC = 6.25% and 12.50%                                                                                                                               in vitro                                                                              \[[@B40-ijms-18-02172]\]                        

  Reducing the lesion diameter of potato inoculated with *F. Sulphureum*                                                                                                                                                                  EOZB and α-Pinene                                                                                                                             6.25% and 12.50%                                                                                                                                     in vivo                                                                               \[[@B40-ijms-18-02172]\]                        

  Inhibitory activity against *B. cinerea*, *P. oryzae*, *P. piricola*, *G. Cingulate*, and *V. pyrina*                                                                                                                                   EEZBL                                                                                                                                         IC~50~ = 11.82 ± 1.15, 12.31 ± 0.45, 39.48 ± 2.25, 13.00 ± 1.34, and 33.22 ± 3.61 mg/mL, respectively                                                in vitro                                                                              \[[@B81-ijms-18-02172]\]                        

  Chloroform fraction of EEZBL                                                                                                                                                                                                            IC~50~ = 9.39 ± 0.07, 4.18 ± 0.08, 10.89 ± 1.62, 0.83 ± 0.24, and 5.35 ± 0.34 mg/mL, respectively                                             in vitro                                                                                                                                             \[[@B81-ijms-18-02172]\]                                                                                                              

  Insecticide effects                                                                                                                                                                                                                     Repellent activity against ants                                                                                                               Piperitone, 4-Terpineol, and Linalool                                                                                                                Not mentioned                                                                         in vitro                                        \[[@B94-ijms-18-02172]\]

  Anti-insect effects towards *T. castaneum*                                                                                                                                                                                              Petroleum ether, Dichloromethane and Diethyl ether fraction of the EOZB                                                                       LD~50~ = 0.0713, 0.11699, and 0.12267 μL                                                                                                             in vitro                                                                              \[[@B95-ijms-18-02172]\]                        

  MEZB                                                                                                                                                                                                                                    0.5, 1.0, and 1.5 mg/mL                                                                                                                       in vitro                                                                                                                                             \[[@B96-ijms-18-02172]\]                                                                                                              

  Anti-insect activity against *aedes albopictus*                                                                                                                                                                                         EOZB                                                                                                                                          15, 25, 35, and 45 μg/mL                                                                                                                             in vitro                                                                              \[[@B96-ijms-18-02172]\]                        

  Insecticidal effects against *L. serricorne* adults                                                                                                                                                                                     EOZB obtained hydrodistillation and supercritical fluid CO~2~                                                                                 LC~50~ = 3.99 and 12.54 μg/mL                                                                                                                        in vitro                                                                              \[[@B41-ijms-18-02172]\]                        

  Anti-insect activity against *L. serricorne*                                                                                                                                                                                            Eucalyptol, Limonene, γ-Terpinene, Linalool, *α*-Terpineol and 4-Terpinenol                                                                   LC~50~ = 5.18, 14.07, 12.01, 18.04, 3.27, and\                                                                                                       in vitro                                                                              \[[@B41-ijms-18-02172]\]                        
                                                                                                                                                                                                                                                                                                                                                                                        6.90 mg/L, respectively                                                                                                                                                                                                                                                                    

  Contact toxicity against *L. serricorne*                                                                                                                                                                                                Eucalyptol, Limonene, γ-Terpinene, Linalool, α-Terpineol and 4-Terpinenol                                                                     LD~50~ = 15.58, 13.66, 14.19, 12.74, 11.99, and\                                                                                                     in vitro                                                                              \[[@B41-ijms-18-02172]\]                        
                                                                                                                                                                                                                                                                                                                                                                                        8.62 μg/adult, respectively                                                                                                                                                                                                                                                                

  Other pharmacological effects                                                                                                                                                                                                           Relaxing subcutaneous muscles                                                                                                                 Sanshools                                                                                                                                            Not mentioned                                                                         in vivo                                         \[[@B97-ijms-18-02172]\]

  Alleviating rice-seedling injury                                                                                                                                                                                                        Sanshools                                                                                                                                     0.8 mg/mL                                                                                                                                            in vitro                                                                              \[[@B98-ijms-18-02172]\]                        

  Prolonging the LPIA                                                                                                                                                                                                                     Seeds of *Z. bungeanum* (SZB)                                                                                                                 0.25, 0.5, and 1.0 g/kg                                                                                                                              in vitro                                                                              \[[@B48-ijms-18-02172]\]                        

  Reduce the cough number                                                                                                                                                                                                                 SZB                                                                                                                                           0.25, 0.5, and 1.0 g/kg                                                                                                                              in vitro                                                                              \[[@B48-ijms-18-02172]\]                        

  Anti-fatigue and anti-anoxia ability                                                                                                                                                                                                    SZB                                                                                                                                           0.5, 1.0, and 2.0 g/kg (i.g.)                                                                                                                        in vitro                                                                              \[[@B48-ijms-18-02172]\]                        

  Enhancing the percutaneous absorption                                                                                                                                                                                                   EOZB                                                                                                                                          3%                                                                                                                                                   in vitro                                                                              \[[@B45-ijms-18-02172]\]                        

  Terpinen-4-ol,1,8-Cineole and Limonene                                                                                                                                                                                                  3%                                                                                                                                            in vitro                                                                                                                                             \[[@B45-ijms-18-02172]\]                                                                                                              

  Decrease serum TC and TG level                                                                                                                                                                                                          *n*-Butanol fraction of *Z. bungeanum*                                                                                                        50 mg/kg and 200 mg/kg (i.g., for 4 weeks)                                                                                                           in vivo                                                                               \[[@B99-ijms-18-02172]\]                        

  Decrease TC, TG, FC level, apoB secretion, and increased apoA1                                                                                                                                                                          *n*-Butanol fraction of *Z. bungeanum*                                                                                                        0.05, 0.1, and 0.2 mg/mL                                                                                                                             in vitro                                                                              \[[@B99-ijms-18-02172]\]                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Pharmacological effects of *Z. bungeanum*.
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###### 

Toxicities and side effects of *Z. bungeanum*.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Extracts/\   Animal/\                          Minimal Toxic Concentration/Dose                                                   Toxic Effects                                    Ref.
  Compounds    Cell Line                                                                                                                                                             
  ------------ --------------------------------- ---------------------------------------------------------------------------------- ------------------------------------------------ ---------------------------
  WEZB         Mice                              LD~50~ = 45 g/kg (i.g., crude herbs mass equal)                                    Death                                            \[[@B16-ijms-18-02172]\]

  WEZB         Mice                              LD~50~ = 51.14 g/kg (i.g., crude herbs mass equal)                                 Death                                            \[[@B100-ijms-18-02172]\]

  WEZB         Mice                              0.5, 1.0, 2.0 and 4.0 g/kg (i.g.)                                                  Ballooning degeneration, cytoplasm rarefaction   \[[@B103-ijms-18-02172]\]

  EOZB         Mice                              (LD~50~ = 2.27, 2.03, 4.64 and 5.32 g/kg of i.g., i.p., i.m., i.h., respectively   Death                                            \[[@B104-ijms-18-02172]\]

  EOZB         HaCaT cells and CCC-ESF-1 cells   IC~50~ = 2.435 mg/mL and 3.649 mg/mL, respectively                                 Inducing cell viability                          \[[@B45-ijms-18-02172]\]

  WEZB         J774.1 cells                      100, 200, and 400 μg/mL (for 18 h)                                                 Non-toxic                                        \[[@B56-ijms-18-02172]\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Toxicities and side effects of *Z. bungeanum.*
